# EDGAR Filing Document

**Accession Number:** 0001295514
**File Stem:** 0001493152-26-023433
**Filing Date:** 2026-5
**Character Count:** 185570
**Document Hash:** bd6b93c6d1730cf71e784b02e5957edc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-023433.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001493152-26-023433

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 71

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MDWerks, Inc.
- **CENTRAL INDEX KEY:** 0001295514
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 331095411
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56299
- **FILM NUMBER:** 26983515

**BUSINESS ADDRESS:**
- **STREET 1:** 411 WALNUT STREET,
- **STREET 2:** SUITE 20125
- **CITY:** GREEN COVE SPRINGS
- **STATE:** FL
- **ZIP:** 32043
- **BUSINESS PHONE:** (252) 501-0019

**MAIL ADDRESS:**
- **STREET 1:** 411 WALNUT STREET,
- **STREET 2:** SUITE 20125
- **CITY:** GREEN COVE SPRINGS
- **STATE:** FL
- **ZIP:** 32043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MDwerks, Inc.
- **DATE OF NAME CHANGE:** 20051117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WESTERN EXPLORATION INC.
- **DATE OF NAME CHANGE:** 20040625

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934**

For the transition period from __________ to __________

**<u>MDwerks, Inc.</u>**

(Exact name of registrant as specified in its charter)

Commission File Number: **<u>000-56299</u>**

---

| | |
|:---|:---|
| **Delaware** | **33-1095411** |
| (State or other jurisdiction or incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**411 Walnut Street, Suite 20125**

**Green Cove, FL 32043**

(Address of Principal Executive Offices) (Zip Code)

**<u>(252) 501-0019</u>**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| N/A | N/A | N/A |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 14, 2026, the Company has 235,710,043 shares of common stock issued and outstanding.

**Table of Contents**

---

| | | |
|:---|:---|:---|
| PART I—FINANCIAL INFORMATION | PART I—FINANCIAL INFORMATION |  |
| Item 1. | Financial Statements |  |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_006) | 4 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_007) | 8 |
| Item 4. | [Controls and Procedures](#a_008) | 8 |
| [PART II—OTHER INFORMATION](#a_009) | [PART II—OTHER INFORMATION](#a_009) | 9 |
| Item 1. | [Legal Proceedings](#a_010) | 9 |
| Item 1A. | [Risk Factors](#a_011) | 9 |
| Item 2. | [Unregistered Sales of Securities and Use of Proceeds](#a_012) | 9 |
| Item 3. | [Defaults Upon Senior Securities](#a_013) | 9 |
| Item 4. | [Mine Safety Disclosure](#a_014) | 9 |
| Item 5. | [Other Information](#a_015) | 9 |
| Item 6. | [Exhibits](#a_016) | 10 |
| [SIGNATURES](#a_017) | [SIGNATURES](#a_017) | 11 |
| [EXHIBIT 31.1](ex31-1.htm) | [EXHIBIT 31.1](ex31-1.htm) |  |
| [EXHIBIT 31.2](ex31-2.htm) | [EXHIBIT 31.2](ex31-2.htm) |  |
| [EXHIBIT 32.1](ex32-1.htm) | [EXHIBIT 32.1](ex32-1.htm) |  |

---

***Forward-Looking Statements***

 ****

*Various statements contained in this report constitute "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are based on current expectations and are indicated by words or phrases such as "believe," "expect," "may," "should," "seek," "plan," "intend" or "anticipate" or the negative thereof or comparable terminology, or by discussion of strategy. Forward-looking statements represent as of the date of this report our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. Such forward-looking statements are based largely on our current expectations and are inherently subject to risks and uncertainties. Our actual results could differ materially from those that are anticipated or projected as a result of certain risks and uncertainties, including, but not limited to, a number of factors, such as: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles and the other risks and uncertainties that are set forth in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations."*

 

*These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the Securities and Exchange Commission ("SEC") pursuant to the SEC's rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, we cannot assure you that the forward-looking information contained in this report will in fact transpire.*

 

*As used in this Quarterly Report on Form 10-Q, unless the context requires or is otherwise indicated, the terms "we," "us," "our," the "Company," "our company" and similar expressions means MDwerks, Inc.*

**Index to Financial Statements**

**As of March 31, 2026**

**and for the Three Months Ended March 31, 2026 and 2025**

---

| | |
|:---|:---|
| [Consolidated Balance Sheets (Unaudited)](#a_001) | F-2 |
| [Consolidated Statements of Operations (Unaudited)](#a_002) | F-3 |
| [Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)](#a_003) | F-4 |
| [Consolidated Statements of Cash Flows (Unaudited)](#a_004) | F-5 |
| [Notes to Consolidated Financial Statements (Unaudited)](#a_005) | F-6 |

---

**MDwerks, Inc.**

Consolidated Balance Sheets

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| **Assets** |  |  |
| &nbsp;&nbsp;&nbsp;**Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | $95754 | $211948 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 24947 | 43489 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | 679582 | 820956 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 165127 | 90659 |
| Total Current Assets | 965410 | 1167052 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed assets, net | 1259054 | 1268555 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 488281 | 502382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of-use asset | 976100 | 628125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 466648 | 466648 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Other non-current assets** | 16010 | 16010 |
| **Total Assets** | $**4171503** | $**4048772** |
| **Liabilities and Stockholders' Equity (Deficit)** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $1558217 | $1560425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable – related party |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes payable | 309341 | 162110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes payable – related party | 167500 | 117500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 478019 | 457178 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of-use liability, current portion | 235234 | 124856 |
| Total Current Liabilities | **2748311** | **2422069** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes payable – related party, net of current portion |  | 38126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes payable, net of current portion |  | 50000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of use liability, net of current portion | 773009 | 536253 |
| **Total Liabilities** | **3521320** | **3046448** |
| **Stockholders' Equity (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, par value $0.001; 10,000,000 shares authorized, of which 0 were issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, par value $0.001; 300,000,000 shares authorized, of which 235,710,043 and 234,105,560 shares were issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 235710 | 234106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid in capital | 7155000 | 6911713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subscription payable | 265000 | 15000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (7005527) | (6158495) |
| Total Stockholders' Equity (Deficit) | 650183 | 1002324 |
| **Total Liabilities and Stockholders' Equity (Deficit)** | $**4171503** | $**4048772** |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**MDwerks, Inc.**

Consolidated Statements of Operations

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **March 31,** | **March 31,** |
|  | **2026** | **2025** |
| Revenues | $434087 | $513930 |
| Cost of revenues | 570350 | 381398 |
| &nbsp;&nbsp;&nbsp;Gross profit | (136263) | 132532 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 487894 | 583905 |
| &nbsp;&nbsp;&nbsp;Salaries and wages | 146054 | 93809 |
| &nbsp;&nbsp;&nbsp;Depreciation expense | 67601 | 72607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 701549 | 750321 |
| Operating loss | (837812) | (617789) |
| Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;Gain (loss) on sale of assets |  |  |
| &nbsp;&nbsp;&nbsp;Other income |  | 200 |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (9220) | (11765) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income (expense) | (9220) | (11565 |
| Net loss | $(847032) | $(629354) |
| Net loss per common share – basic | $(0.00) | $(0.00) |
| Net loss per common share – diluted | $(0.00) | $(0.00) |
| Weighted average common shares outstanding |  |  |
| Basic | 235456983 | 210632031 |
| Diluted | 235456983 | 210632031 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**MDwerks, Inc.**

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

(Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br> **Paid-in**<br>**Capital** | **Subscription**<br>**Payable** | **Accumulated**<br>**Deficit** |<br>**Total** |
| **Balance December 31, 2024** |  | $- | 204744872 | $204745 | $2511788 | $15000 | $(2360505) | $371028 |
| Common shares sold for cash |  |  | 9493332 | 9493 | 1414507 | 160000 |  | 1584000 |
| Common shares issued for inventory |  |  | 5000000 | 5000 | 845000 |  |  | 850000 |
| Stock based compensation |  |  | 692858 | 693 | 51379 | 14250 |  | 66322 |
| Net loss |  | - | - | - | - | - | (629354) | (629354) |
| **Balance March 31, 2025** |  | $- | 219931062 | $219931 | $4822674 | $189250 | $(2989859) | $2241996 |
| **Balance December 31, 2025** |  | $- | 234105560 | $234106 | $6911713 | $15000 | $(6158495) | $1002324 |
| Common shares sold for cash |  |  | 1333333 | 1333 | 198667 | 250000 |  | 450000 |
| Stock based compensation |  |  | 271150 | 271 | 44620 |  |  | 44891 |
| Net loss |  | - | - | - | - | - | (847032) | (847032) |
| **Balance March 31, 2026** |  | $- | 235710043 | $235710 | $7155000 | $265000 | $(7005527) | $650183 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**MDwerks, Inc.**

Consolidated Statements of Cash Flows

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(847032) | $(629354) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 67601 | 72607 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 44891 | 66322 |
| &nbsp;&nbsp;&nbsp;Inventory impairment | 28988 |  |
| &nbsp;&nbsp;&nbsp;Allowance for credit losses | (8148) | 11715 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 26690 | 2365 |
| &nbsp;&nbsp;&nbsp;Prepaid expense | 73505 | 18490 |
| &nbsp;&nbsp;&nbsp;Inventory | 112386 | (17537) |
| &nbsp;&nbsp;&nbsp;Right-of-use asset | 102891 | 60686 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 16701 | 37030 |
| &nbsp;&nbsp;&nbsp;Accounts payable – related |  | (46812) |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 20841 | 83216 |
| &nbsp;&nbsp;&nbsp;Right-of-use liability | (103732) | (80044) |
| **NET CASH USED IN OPERATING ACTIVITIES** | (464418) | (421316) |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (62907) | (604377) |
| **NET CASH USED IN INVESTING ACTIVITIES** | (62907) | (604377) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from related party notes payable |  | 150000 |
| &nbsp;&nbsp;&nbsp;Repayment of related party notes payable |  | (55500) |
| &nbsp;&nbsp;&nbsp;Repayment of notes payable | (38869) | (70791) |
| &nbsp;&nbsp;&nbsp;Proceeds from subscription agreements | 450000 | 1584000 |
| **NET CASH PROVIDED BY FINANCING ACTIVITIES** | 411131 | 1607709 |
| **NET CHANGE IN CASH** | (116194) | 582016 |
| **CASH - BEGINNING OF YEAR** | 211948 | 11159 |
| **CASH - END OF PERIOD** | $95754 | $593175 |
| **Supplemental disclosures of cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $2250 | $276 |
| &nbsp;&nbsp;&nbsp;Cash paid for taxes | $- | $- |
| **Supplemental disclosure of non-cash investing and financing activities** |  |  |
| Right of use asset, operating lease | $450866 | $- |
| Common stock issued for inventory | $- | $850000 |
| Insurance premium financed with a note payable | $147973 | $171050 |

---

The accompanying notes are an integral part of these unaudited consolidated financial statements.

**MDwerks, Inc.**

Notes to Unaudited Consolidated Financial Statements

For the Three Months Ended March 31, 2026 and 2025

**NOTE 1 - ORGANIZATION AND DESCRIPTION OF THE BUSINESS**

MDwerks, Inc. (the "Company"), a Delaware corporation, was focused on effecting a "reverse merger," capital exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more unrelated businesses (the "Business Combination") that would benefit from the Company's public reporting status. The Company has two lines of business as outlined below from acquisitions completed in 2023.

Two Trees Beverage Co. ("Two Trees") produces a variety of aged alcoholic beverages using an innovative rapid-aging system. This scalable technology results in all-natural, high-quality products, efficiently produced, with a reduced environmental impact. Our products are nearly indistinguishable from those that are traditionally aged. Two Trees created a proprietary process that mirrors and accelerates the natural aging process that occurs when alcohol is aged in wooden barrels over time. The true art of our craft spirits lives within the balance between the grain selection, local water, and the full-bodied flavors from our toasted wood chip varieties. Our wood chips are selected to pair with specific grains and toasted to just the right char, bringing rich flavor profiles to life with a hint of smoke.

RF Specialties, LLC ("RFS") is an innovative company pushing the boundaries of sustainable Radio Frequency applications. For over 12 years, RF Specialties has addressed companies' most pressing challenges by implementing automated Radio Frequency Technology in a sustainable way and reducing energy costs and increasing speed to market when compared to traditional methods. By bringing Radio Frequency applications to market RFS has successfully elevated a wide range of industries including structural engineering, food & beverage, and manufacturing.

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation -** The accompanying interim unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission ("SEC") on March 25, 2026. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been omitted from this Quarterly Report on Form 10-Q pursuant to the rules and regulations of the SEC.

Results for the interim periods in this report are not necessarily indicative of future financial results and have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary to present fairly our interim financial statements as of March 31, 2026, and for the three months ended March 31, 2026 and 2025. These adjustments are of a normal recurring nature and consistent with the adjustments recorded to prepare the annual audited consolidated financial statements as of December 31, 2025.

The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Two Trees Beverage Company, Prost Beverage Co, Radio Aged Beer LLC, RF Kettle Company LLC, Two Trees, Drilling, RAS LLC, (collectively referred to as "Two Trees") and RF Specialties, LLC. All intercompany accounts, transactions and balances have been eliminated in consolidation.

**Use of Estimates and Assumptions -** The preparation of financial statements in accordance with US GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.

**Accounts Receivable and the Allowances for Credit losses** - Accounts receivable are recorded in the period when the right to receive payment or other consideration becomes unconditional. Accounts receivable are recorded at the invoiced amount and do not earn interest. The Company maintains an allowance for credit losses based upon the best estimate of probable credit losses in existing accounts receivable. The Company determines the allowance based upon individual accounts when information indicates the customers may have an inability to meet their financial obligations, as well as historical collection and write-off experience. The Company had an accounts receivable balance of $24,947 net of $1,976 allowance for doubtful accounts as of March 31, 2026. The Company had an accounts receivable balance of $43,489 net of $10,627 allowance for doubtful accounts as of December 31, 2025. The Company had credit losses (recoveries) of $(8,148) and $11,715 during the three months ended March 31, 2026 and 2025, respectively. As of and for the three months ended March 31, 2026, the Company had three customers that accounted for 30%, 28% and 16% of total accounts receivable. As of December 31, 2025, the Company had four customers that accounted for 35%, 23%, 14%, and 14% of total accounts receivable.

**Prepaid Expenses and Other Assets -** Prepaid expenses primarily consist of prepaid purchases, insurance, income tax refund receivable, and various other expenses. These amounts are recognized as an expense in the period the related service or benefit is received.

**Fair value of financial instruments** - The Company measures its financial and non-financial assets and liabilities, as well as makes related disclosures, in accordance with FASB Accounting Standards Codification No. 820, Fair Value Measurement ("ASC 820"), which provides guidance with respect to valuation techniques to be utilized in the determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the income approach (present value of future income or cash flow), and (iii) the cost approach (cost to replace the service capacity of an asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one more significant inputs or significant value drivers are unobservable.

The carrying values of the Company's accounts payable and accrued liabilities, advances payable, and convertible notes payable, approximate their fair value due to their short-term nature.

**Going Concern** - These financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. As reflected in the accompanying financial statements, the Company had loss of $847,032 for the three months ended March 31, 2026 and an accumulated deficit of $7,005,527 as of March 31, 2026 Although management believes that it will be able to successfully execute its business plans, which includes third party financing and raising capital to meet the Company's future liquidity needs, there can be no assurances in this regard. These matters raise substantial doubt about the Company's ability to continue as a going concern.

**Revenue Recognition** - Net sales from Two Trees include liquor and related products, less excise taxes and customer programs and incentives. Sales from RF Specialties, LLC will include product and services related to sustainable Radio Frequency applications to a wide range of industries including structural engineering, food & beverage, and manufacturing. The Company recognizes revenue by applying the following steps in accordance with Accounting Standards Codification ("ASC") Topic 606 – Revenue from Contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

The Company recognizes sales when merchandise is shipped from a warehouse directly to wholesale customers (except in the case of a consignment sale). For consignment sales, which include sales to the Oregon Liquor Control Commission, the Company recognizes sales upon the consignee's shipment to the customer. Postage and handling charges billed to customers are also recognized as sales upon shipment of the related merchandise. Shipping terms are generally FOB shipping point, and title passes to the customer at the time and place of shipment or purchase by customers at a retail location. For consignment sales, title passes to the consignee concurrent with the consignee's shipment to the customer. The customer has no cancellation privileges after shipment or upon purchase at retail locations, other than customary rights of return. For service revenue within the Company's radio frequency applications, the Company recognizes revenue as the services are provided to the customer. The Company's contracts typically have a single performance obligation, and do not contain a significant financing component.

The Company recognizes deferred revenue for performance obligations not yet satisfied, primarily related to liquor sales not yet shipped. As of March 31, 2026 and December 31, 2025, the Company had $478,019 and $457,158, respectively, in unsatisfied performance obligations that it expects to satisfy over the next 12 months.

During the three months ended March 31, 2026, the Company's revenue consisted of liquor sales from the Two Trees and RF Specialties and labor costs related to the product and service income resulting from the RF Specialties and Two Trees Distilling.

For the three months ended March 31, 2026, the Company had one customer who accounted for 16% of total revenue.

For the three months ended March 31, 2025, the Company had one customer who accounted for 29% of total revenue.

**Inventory** - Inventories primarily consist of bulk and bottled liquor and raw materials and are stated at the lower of cost or market. Cost is determined using an average costing methodology, which approximates cost under the first-in, first-out ("FIFO") method. A portion of the Company's finished goods inventory is held in warehouses located in several states that maintain control over the alcohol beverage distribution process until it is sold into the retail distribution channel within those states. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based primarily on the Company's estimated forecast of product demand and production requirements. Such write-downs establish a new cost basis of accounting for the related inventory.

**Intangible Assets** - Intangible assets, consisting of trade names, developed technology, and customer relationships, are accounted for in accordance with ASC 350 Intangibles - Goodwill and Other. Intangible assets that have finite lives are amortized using the straight-line method over their estimated useful lives of three to fifteen years.

**Goodwill** - Goodwill represents the excess of acquisition cost over the fair value of the net tangible and intangible assets acquired. Goodwill is not amortized and is subject to annual impairment testing on or between annual tests if an event or change in circumstance occurs that would more likely than not reduce the fair value of a reporting unit below its carrying value. In testing for goodwill impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it can conclude the assessment. If the Company concludes otherwise, the Company is required to perform a quantitative analysis to determine the amount of impairment. A quantitative analysis is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value to determine the amount of impairment, if any. The Company has determined that it has one reporting unit. During the three months ended March 31, 2026, and 2025, no impairment expense was recognized.

**Impairment of Long-Lived Assets** - Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair market value of the assets. During the three months ended March 31, 2026, and 2025, no impairment expense was recognized.

**Leases** - Management determines if an arrangement is a lease at the inception of the agreement. Operating leases are included in operating lease right-of-use (ROU) assets and operating lease liability on the accompanying consolidated balance sheet. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants.

ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. The operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the rate implicit in the lease agreement, when available, or a discount rate based on the information available at the commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

**Property and Equipment -** Property and equipment are recorded at cost. Depreciation of property and equipment is calculated on a straight-line basis over the estimated useful lives of the assets. Furniture and fixture assets are depreciated over five years, vehicles are depreciated over five years, and computer and equipment are depreciated over three years. Expenditures for renewals and betterments that extend the useful lives of or improve existing property or equipment are capitalized. Expenditures for maintenance and repairs are expensed as incurred. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

---

| | |
|:---|:---|
| **Category** | **Estimated**<br> **Useful Lives** |
| Machinery and equipment | 3-7 years |
| Vehicles | 5 years |
| Furniture & Fixtures | 5 years |
| Computers | 3 years |

---

Leasehold improvements are depreciated over the shorter period of their estimated useful life or term of the lease.

**Research and Development Expenses** - The Company records research and development expenses in the period in which they are incurred as a component of product development expenses.

**Stock-Based Compensation** - The Company measures stock-based compensation at the estimated fair value on the grant date and recognizes the amortization of stock-based compensation expense on a straight-line basis over the requisite service period, or when it is probable criteria will be achieved for performance-based awards. Fair value is determined based on assumptions related to the fair value of the Company common stock, stock volatility and risk-free rate of return. The Company has elected to recognize forfeitures when realized.

**Excise Taxes** - The Company is responsible for compliance with the Alcohol and Tobacco Tax and Trade Bureau ("TTB") regulations, which includes making timely and accurate excise tax payments. The Company is subject to periodic compliance audits by the TTB. Individual states also impose excise taxes on alcoholic beverages in varying amounts. The Company calculates its excise tax expense based upon units produced and on its understanding of the applicable excise tax laws. Excise taxes totaled $8,382 and $7,232 for the three months ended March 31, 2026 and 2025, respectively.

**Segment Reporting** - In November 2023, the Financial Accounting Standard Board ("<u>FASB</u>") issued ASU 2023-07, *Improvements to Reportable Segment Disclosures*, which amends the existing segment reporting guidance (ASC Topic 280) to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount for other segment items by reportable segment and a description of its composition, the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources.

**Reclassifications** – Certain prior period amounts have been reclassified to conform to current period presentation.

**Recently Issued Accounting Pronouncements** - From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective will not have a material effect on its financial position or results of operations upon adoption.

In November 2024, the FASB issued ASU 2024-03, *Disaggregation of Income Statement Expenses (DISE)*, requiring additional disclosure of the nature of expenses included in the income statement. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of our pending adoption of this standard on our consolidated financial statements.

**NOTE 3 - INVENTORY**

Inventories primarily consist of bulk and bottled liquor and raw materials and are stated at the lower of cost or market. Cost is determined using an average costing methodology, which approximates cost under the first-in, first-out ("FIFO") method. A portion of the Company's finished goods inventory is held in warehouses located in several states that maintain control over the alcohol beverage distribution process until it is sold into the retail distribution channel within those states. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based primarily on the Company's estimated forecast of product demand and production requirements. Such write-downs establish a new cost basis of accounting for the related inventory.

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Raw materials | $641965 | $832285 |
| Finished goods and packaging | 179352 | 124295 |
| Inventory allowance | (141735) | (135624) |
| Total inventories | $679582 | $820956 |

---

During the three months ended March 31, 2026, the Company recognized an impairment of $28,988 related to barrel inventory with a market price below the Company's carrying value.

**NOTE 4 – FIXED ASSETS, NET**

Fixed assets, net consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Machinery and equipment | $1233929 | $647369 |
| Furniture and office equipment | 264584 | 262890 |
| Buildings | 10497 | 10497 |
| Construction in progress | 299216 | 843471 |
| Total Property and equipment | 1808226 | 1764227 |
| Less accumulated depreciation | (549172) | (495672) |
| Total property and equipment, net | $1259054 | $1268555 |

---

Two Trees entered into two contracts with two spirit companies for the deployment and license of our proprietary Spirits Rapid Aging System ("SRAS"). The first contract is for the building and deployment of SRAS at the customer's facilities within the next three months, with the potential for additional SRAS deployments in the next 12 months. The second contract is for the building and deployment of SRAS at the customer's facilities within the next six to nine months, with the potential for additional SRAS deployments in the next 12 months. Under both agreements, RFS will assemble the SRAS units and provide ongoing machine servicing and maintenance, thereby is entitled to receive recurring monthly license payments from the customers for use of the SRAS units. The Company is constructing the machines which expect to be deployed by the end of fiscal year ended December 31, 2026.

Depreciation expense totaled $53,500 and $58,506 for the three months ended March 31, 2026, and 2025, respectively.

**Asset purchase agreements**

Prior to its acquisition by the Company on December 27, 2023, RFS entered into two asset purchase agreements to acquire certain tools and equipment. The Company received assets under one agreement in December 2023, totaling $97,363. The assets are included in property and equipment on the Company's consolidated balance sheet. The Company assumed the liability of $88,674 as part of the Exchange Agreement with RFS. The agreement requires monthly payments through October 2026.

On January 31, 2024, the Company received assets under the second purchase agreement totaling $444,891. The assets are included in property and equipment on the Company's consolidated balance sheet. The Company assumed the liability of $444,891 as part of the Exchange Agreement with RFS. The Exchange Agreement requires monthly payments through March 2027.

**NOTE 5 – INTANGIBLE ASSETS, NET**

Intangible assets, net consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Trade names and license, 10 year estimated useful life | $359500 | $359500 |
| Developed technology, 15 year estimated useful life | 140000 | 140000 |
| Customer relationships, 10 year estimated useful life | 120000 | 120000 |
| Total intangible assets | 619500 | 619500 |
| Less accumulated amortization | (131219) | (117118) |
| Total intangible assets, net | $488281 | $502382 |

---

Total amortization expense for the three months ended March 31, 2026 and 2025 was $14,101 and $14,101, respectively. The Company expects to recognize amortization expense of $56,402 annually in each of the next five years.

On February 5, 2024, the Company, through its wholly owned subsidiary, Two Trees Beverages, entered into a new 15-year license agreement with Shine Time, LLC, licensing territories for *Tim Smith Spirits*® expanding its territories beyond the United States to include all members of the European Union, the United Kingdom, Norway, Switzerland, Iceland, Serbia, Turkey and Ukraine. The Company agreed to pay a royalty of 9% on branded products covered by the license agreement, or 4.5% of any sublicensed revenue under the agreement. During the year ended December 31, 2024, the Company paid $79,688 to Shine Time, LLC pursuant to the license agreement. An additional $112,500 was due under the terms of the license agreement by April 1, 2024. As of the filing date of this Quarterly Report on Form 10-Q, the Company has not paid such amount. The Company also agreed to issue to Shine Time, LLC 300,000 shares of the Company's common stock with a fair value of $15,000. Such shares have not been issued as of the date of this report. As of March 31, 2026 and December 31, 2025, the royalty payable balance was $149,495 and $135,872, respectively, included in accounts payable and accrued expenses on the consolidated balance sheets.

**NOTE 6 - NOTES PAYABLE**

The Company has the following outstanding notes payable:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Loans** | **Origination**<br> **Date** | **Interest**<br> **Rate** | **Balance as of**<br> **March 31, 2026** | **Balance as of**<br> **December 31, 2025** |
| Asset purchase agreement notes | December 1, 2023 and January 31, 2024 | 0.00% | $139785 | $178652 |
| Termination Agreement | December 31, 2021 | 0.13% | 21584 | 21584 |
| Insurance Note payable | December 14, 2026 | 9.70% | 147792 |  |
| Advances and Notes Payable – Related parties | Various | 10.00%-12.00 | 167500 | 167500 |
| Total notes payable |  |  | 476841 | 367736 |
| Less current portion |  |  | (476841) | (279610) |
| Total long term |  |  | $- | $88126 |

---

The following is a summary of the future minimum payments of loans payable:

---

| | |
|:---|:---|
| **12 months ending:** | |
| March 31, 2027 | 476841 |
| March 31, 2028 |  |
| March 31, 2029 | - |
| Total loans payable | $476841 |

---

During the year ended December 31, 2020, the Company entered into a termination agreement in which it agreed to pay the sum of $50,000. During the year ended December 31, 2021, the Company issued a promissory note payable in the amount of $31,584 at the rate of 0.13% per annum, with a maturity date on or before January 1, 2025, for settlement of the $50,000 agreed upon in the termination agreement. The balance as of March 31, 2026, and December 31, 2025, is $21,584.

Prior to its acquisition by the Company on December 27, 2023, RFS entered into two asset purchase agreements to acquire certain tools and equipment.

The Company received assets under the first asset purchase agreement in December 2023, totaling $97,363. The assets are included in property and equipment on the Company's consolidated balance sheet. The Company assumed the liability of $88,674 as part of the Exchange agreement with RF Specialties. The agreement requires monthly payments through October 2026.

On January 31, 2024, the Company received assets under the second asset purchase agreement totaling $444,891. The assets are included in property and equipment on the Company's consolidated balance sheet. The Company assumed the liability of $444,891 as part of the Exchange Agreement with RFS. The agreement requires monthly payments through March 2030.

During the year ended December 31, 2025, the Company received a total of $150,000 in proceeds from shareholders. The advances are unsecured, due on demand and have stated interest of 10% per annum. As of March 31, 2026 and December 31, 2025, the balance owed on the advances from shareholders was $167,500 respectively.

In February 2026, the Company entered into an insurance policy financing arrangement. The total principal was $147,793 with an interest rate of 9.70% and monthly payments of $12,437 due through December 2026. The Company made principal payments of $28,956 during the three months ended March 31, 2026. As of March 31, 2025, the remaining balance was $147,792.

Interest expense of $9,220 and $11,765 was recorded in the three months ended March 31, 2026, and 2025, respectively. Accrued interest as of March 31, 2026 and December 31, 2025, was $35,711 and $30,355, respectively.

**NOTE 7 - CAPITAL STOCK**

**Preferred stock**

The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value, with such designations, rights and preferences as may be determined from time to time by the Board of Directors, of which 10,000,000 shares are designated Series A Convertible Preferred.

On June 15, 2014, the Company designated rights and preferences to the Series A Convertible Preferred stock. Each share of Series A Convertible Preferred stock may be converted into one hundred (100) shares of common stock. Additionally, each share of Series A Preferred stock holds the same number of common stock share votes into which it is convertible, prior to being converted, for the purposes of voting on any company matter requiring a vote of shareholders.

On November 7, 2024, the Company agreed to purchased 8,957,000 shares of Series A Convertible Preferred stock, representing all of the issued and outstanding shares of Series A Convertible Preferred shares of the Company from, Tradition Reserve I LLC, a New York limited liability company, in exchange for $10. At March 31, 2026 and December 31, 2025, there were 0 shares of Series A Convertible Preferred issued and outstanding.

**Common stock**

The Company is authorized to issue 300,000,000 shares of Common stock, $0.001 par value, with such designations, rights and preferences as may be determined from time to time by the Board of Directors.

During the three months ended March 31, 2026, the Company sold 2,833,333 shares of common stock in exchange for cash proceeds of $450,000. A total of 2,500,000 shares of common stock were not issued as of the date of this report related to $250,000 of cash proceeds, which is included in subscription payable on the consolidated balance sheet. The Company has also not yet issued 300,000 shares of common stock related to a prior royalty agreement which are included in subscriptions payable on the Company's consolidated balance sheet at a value of $15,000.

During the three months ended March 31, 2026, the Company issued a total of 271,150 shares of common stock to officers, directors and consultants for services under the agreements discussed in Note 8. The Company recorded stock-based compensation of $44,891 under the agreements, based on the common stock prices ranging from $0.13 to $0.15 on the respective grant dates.

During the three months ended March 31, 2025, the Company sold 10,559,999 shares of common stock in exchange for cash proceeds of $1,584,000. A total of 1,066,667 shares of common stock were not issued as of the date of this report related to $160,000 of cash proceeds, which are included in subscriptions payable on the Company's consolidated balance sheet.

During the three months ended March 31, 2025, the Company issued a total of 692,858 shares of common stock to officers, directors and consultants for services under the agreements discussed in Note 9. The Company recorded stock-based compensation of $66,322 under the agreements, based on the common stock prices ranging from $0.12 to $0.30 on the respective grant dates.

At March 31, 2026 and December 31, 2025, there were 235,710,043 and 234,105,560 shares issued and outstanding, respectively.

**Warrants**

The following table represents warrant activity during the three months ended March 31, 2026:

---

| | | |
|:---|:---|:---|
|  | Number of Options | Weighted Average Exercise Price |
| Outstanding at December 31, 2025 | 17262656 | $1.50 |
| Granted |  |  |
| Forfeited, cancelled | - | - |
| Outstanding at March 31, 2026 | 17262656 | $1.50 |
| Exercisable at March 31, 2026 | 17262656 | $1.50 |

---

The warrants had a weighted average remaining life of 2.40 years and no intrinsic value as of March 31, 2026.

**Stock options**

The following is a summary of activity of outstanding stock options during the three months ended March 31, 2026:

---

| | | |
|:---|:---|:---|
|  |<br>Number<br>of Options | Weighted<br>Average<br>Exercise<br>Prices |
| Balance, December 31, 2025 | 4650685 | $0.36 |
| &nbsp;&nbsp;&nbsp;Granted |  |  |
| &nbsp;&nbsp;&nbsp;Cancelled | - | - |
| Balance, March 31, 2026 | 4650685 | $0.36 |
| Exercisable, March 31, 2026 | 4650685 | $0.36 |

---

The options had a weighted average remaining life of 7.69 years and no intrinsic value as of March 31, 2026.

**Stock Appreciation Rights**

On July 15, 2025, the Company awarded a total of 2,180,000 Stock Appreciation Rights ('SARs") to the Company's common stock to the employees under the 2025 Plan at an exercise price of $0.22 per share, vesting immediately, with a 10 year exercise period. The Company has the sole discretion to settle the SARs in shares or cash. The Company will issue shares when exercised based on the difference between the fair value on the exercise date and the exercise price of $0.22. The SARs are classified as equity instruments in accordance with ASC 718.

The following is a summary of activity of outstanding SARs during the three months ended March 31, 2026:

---

| | | |
|:---|:---|:---|
|  |<br>Number of SARs | Weighted Average<br>Exercise Prices |
| Balance, December 31, 2025 | 2180000 | $0.22 |
| &nbsp;&nbsp;&nbsp;Granted |  |  |
| &nbsp;&nbsp;&nbsp;Cancelled | (250000) | 0.22 |
| Balance, March 31, 2026 | 1930000 | $0.22 |
| Exercisable, March 31, 2026 | 1930000 | $0.22 |

---

**NOTE 8 - COMMITMENTS AND CONTINGENCIES**

In the ordinary course of business, the Company may become a party to lawsuits involving various matters. The impact and outcome of litigation, if any, is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company believes the ultimate resolution of any such current proceeding will not have a material adverse effect on our continued financial position, results of operations or cash flows.

On April 22, 2024, the Company entered into a broker agreement with a third party. Under the agreement, the Company will pay a monthly fee of $1,500, and a commission of 12% of any revenue from customers introduced by the broker, less any promotional expenses incurred by the Company. The agreement is cancellable by either party with 60 days' notice, and in the event of termination, the commissions shall continue for a period of one year from the termination date. Under the broker agreement, the Company incurred fees of $0 and $1,500 during the three months ended March 31, 2026 and 2025, respectively, and owed the broker $0 as of March 31, 2026.

In August 2024, the Company entered into an affiliate agreement with an independent contractor, whereby the Company agreed to pay the contractor a commission of 5% of gross revenue related to any SRAS system sales or sales from aging services performed by the Company through customers introduced by the contractor. The agreement has a term of 10 years, and provides the contractor with exclusivity rights to provide its services to the Company. During the year ended December 31, 2025, the Company incurred commissions of $11,150 and owed $11,150 as of March 31, 2026 and December 31, 2025, respectively.

On November 6, 2024, the Company entered into an employment agreement with its CEO, Steve Laker. The agreement specifies an annual salary of $180,000 through December 31, 2025, $225,000 2026, $250,000 for 2027, $300,000 for 2028 and $350,000 for 2029. Mr. Laker is also eligible to receive a cash performance-based bonus for any quarter over the next two years where the Company's gross revenue has increased by at least 25% compared to the previous year quarter. The bonus per quarter would be 25% of Mr. Laker's then-current base salary. After two years, for any calendar year where gross revenue has increased at least 10%, 15% or 25%, Mr. Laker will be eligible to a bonus of 50%, 100% or 150%, respectively, of his then-current base salary, and is payable 50% in cash and 50% in Company stock vesting over the following 24 months. Upon execution of the agreement, the Company will issue 500,000 shares of common stock to Mr. Laker, with 25% vesting on January 1, 2025 and the remainder monthly from January 1, 2026 through December 31, 2028. During the three months ended March 31, 2026 and 2025, the Company recognized expense of $3,063 and $0 for these awards and expects to recognize an additional $33,688 through the end of the vesting period. Additionally, Mr. Laker is eligible to receive an additional 3,000,000 shares of common stock based on performance benchmarks tied to certain revenue targets, with targets ranging from $5,000,000 to $50,000,000. These performance awards had a grant date fair value of $294,000. The Company recognized no expense during the three months ended March 31, 2026 and 2025 related to these awards as vesting was not deemed probable. The expense related to the performance awards will be recognized when vesting becomes probable. The agreement has an initial term of five years, and renewal automatically unless written notice is provided 90 days prior. The agreement can be terminated by the Company for cause with 90 days notice. In the event of termination of Mr. Laker without cause, Mr. Laker will receive one year of his then-current base salary, and all stock awards under the agreement will become fully vested.

On November 6, 2024, the Company entered into an employment agreement with its Executive Chairman James Cassidy. The agreement specifies an annual salary of $180,000 through December 31, 2025, $225,000 for 2026, $250,000 for 2027, $300,000 for 2028 and $350,000 for 2029. Mr. Cassidy is also eligible to receive a cash performance-based bonus for any quarter over the next two years where the Company's gross revenue has increased by at least 25% compared to the previous year quarter. The bonus per quarter would be 25% of Mr. Cassidy's then-current base salary. After two years, for any calendar year where gross revenue has increased at least 10%, 15%, or 25% Mr. Cassidy will be eligible to a bonus of 50%, 100% or 150%, respectively, of his then-current base salary, and is payable 50% in cash and 50% in Company stock vesting over the following 24 months. Upon execution of the agreement, the Company issued 500,000 shares of common stock to Mr. Cassidy, with 25% vesting on January 1, 2025 and the remainder monthly from January 1, 2026 through December 31, 2028. During the three months ended March 31, 2026 and 2025, the Company recognized expense of $3,063 and $0 for these awards and expects to recognize an additional $33,688 through the end of the vesting period. Additionally, Mr. Cassidy is eligible to receive an additional 3,000,000 shares of common stock based on performance benchmarks tied to certain revenue targets, with targets ranging from $5,000,000 to $50,000,000. These performance awards had a grant date fair value of $294,000. The Company recognized no expense during the three months ended March 31, 2026 and 2025 related to these awards as vesting was not deemed probable. The expense related to the performance awards will be recognized when vesting becomes probable. The agreement has an initial term of five years, and renewal automatically unless written notice is provided 90 days prior. The agreement can be terminated by the Company for cause with 90 days notice. In the event of termination of Mr. Cassidy without cause, Mr. Cassidy will receive one year of his then-current base salary, and all stock awards under the agreement will become fully vested.

On November 18, 2024, Mr. Timothy Brocopp and the Company entered into an Independent Director Agreement, with the following summarized terms: Mr. Brocopp shall serve as an independent director of the Company and be available to perform the duties consistent with such position pursuant to the Certificate of Incorporation and Bylaws of the Company. Mr. Brocopp's employment commenced on Monday, November 16, 2024, and continues for a term of three (3) years. Compensation that Mr. Brocopp will receive during his term includes the sum of $5,000, each calendar quarter, payable in the third month of each calendar quarter, and with such amount for any partial calendar quarter being appropriately prorated. The Company issued an initial 100,000 shares of common stock to Mr. Brocopp 100,000 shares of common stock upon execution of the agreement, subject to the terms and conditions of the Company's applicable equity incentive plan and any related grant documentation, and will issue an additional $10,000 of shares each quarter based on a VWAP schedule using the previous 20 Trading days at quarter end. During the three months ended March 31, 2026, the Company issued 85,575 shares to Mr Brocopp for shares earned in 2025. Furthermore, the Company is to issue an additional 46,546 shares of common stock with a fair value of $6,288 based on the closing price of the Company's common stock as of March 31, 2026. As of the date of this report, the Company has not issued the 46,546 shares of common stock to Mr. Brocopp.

On December 3, 2024, Mr. Richard Blackstone and the Company entered into an Independent Director Agreement. Mr. Blackstone shall serve as an independent director of the Company and be available to perform the duties consistent with such position pursuant to the Certificate of Incorporation and Bylaws of the Company. Mr. Blackstone's employment commenced on Tuesday, December 3, and continues for a term of three (3) years. Compensation that Mr. Blackstone will receive during his term includes the sum of $5,000, each calendar quarter, payable in the third month of each calendar quarter, and with such amount for any partial calendar quarter being appropriately prorated. Upon employment, the Company shall issue to Mr. Blackstone 100,000 shares of common stock, par value $0.001 per share, of the Company (the "Common Stock"), subject to the terms and conditions of the Company's applicable equity incentive plan and any related grant documentation, and will issue an additional $10,000 of shares each quarter based on a VWAP schedule using the previous 20 Trading days at quarter end. During the three months ended March 31, 2026, the Company issued 85,575 shares to Mr. Blackstone for shares earned in 2025. Furthermore, the Company is to issue an additional 46,546 shares of common stock with a fair value of $6,288 based on the closing price of the Company's common stock as of March 31, 2026. As of the date of this report, the Company has not issued the 46,546 shares of common stock to Mr. Blackstone.

On March 10, 2025, the Company entered into an Executive Employment Agreement with David Stephens. Mr. Stephens shall serve as the Chief Financial Officer of the Company. Mr. Stephen's employment commenced on March 1, 2025, and continues for a term of three (3) years. Compensation that Mr. Stephens will receive during his term includes (i) for the period of January 1, 2025 through December 31, 2025, a base salary of $120,000, payable in equal monthly payments of $10,000 per month; (ii) for the period of January 1, 2026 through December 31, 2026, a base salary of $150,000; and (iii) for the period of January 1, 2027 through December 31, 2027, a base salary of $175,000. In addition to the Base Salary, Mr. Stephens shall receive performance-based bonuses from January 1, 2025 on a quarterly basis for a period of two (2) years of the Term (the "Two Year Quarterly Bonuses") as follows: for any calendar quarter(s) where the Company's gross revenue has increased a minimum of twenty five percent (25%) from its prior year gross revenue for that corresponding calendar quarter, Mr. Stephens shall be entitled to a cash bonus equating to fifteen percent (15%) of his then-current Base Salary within thirty (30) days of the conclusion of any such calendar quarter(s). Upon conclusion of the two (2) years of the Term, Mr. Stephens shall thereafter receive performance-based bonuses on an annual basis (the "Subsequent Annual Bonuses"). For any calendar year(s) where the Company's gross revenue has increased a minimum of ten percent (10%) from its prior year gross revenue for that corresponding calendar year, Mr. Stephens shall be entitled to a cash bonus equating to forty percent (40%) of his then-current Base Salary payable as follows: (1) fifty percent (50%) in cash within thirty (30) days of the conclusion of any such calendar year(s); and (2) fifty percent (50%) in Company stock vesting on a prorated consecutive twenty four (24) calendar month basis; For any calendar year(s) where the Company's gross revenue has increased a minimum of fifteen percent (15%) from its prior year gross revenue for that corresponding calendar year(s), Mr. Stephens shall be entitled to a cash bonus equating to seventy-five percent (75%) of his then-current Base Salary payable as follows: (1) fifty percent (50%) in cash within thirty (30) days of the conclusion of any such calendar year(s); and (2) fifty percent (50%) in Company stock vesting on a prorated consecutive twenty four (24) calendar month basis.; For any calendar year(s) where the Company's gross revenue has increased a minimum of twenty five percent (25%) from its prior year gross revenue for that corresponding calendar year(s), Mr. Stephens shall be entitled to a cash bonus equating to one hundred twenty five percent (125%) of his then-current Base Salary payable as follows: (1) fifty percent (50%) in cash within thirty (30) days of the conclusion of any such calendar year(s); and (2) fifty percent (50%) in Company stock vesting on a prorated consecutive twenty four (24) calendar month basis.

Upon execution of the agreement, the Company issued 150,000 shares of common stock to Mr. Stephens with a fair value of $27,000, with 50,000 shares vesting on execution of the agreement and the remainder monthly from January 1, 2026 through December 31, 2027. The Company recognized expense of $1,500 and $9,000 for these awards during the three months ended March 31, 2026 and 2025, respectively and expects to recognize an additional $16,500 through the end of the vesting period. Additionally, Mr. Stephens is eligible to receive an additional 562,500 shares of common stock based on performance benchmarks tied to certain revenue targets, with targets ranging from $5,000,000 to $50,000,000. These performance awards had a grant date fair value of $101,250. The Company recognized no expense during the three months ended March 31, 2026 related to these awards as vesting was not deemed probable.

On March 14, 2025, the Company agreed to issue 200,000 shares of common stock to a consultant, of which 66,667 vest upon execution, and the remaining 133,333 monthly vesting from January 1, 2026 through December 31, 2027. The shares were valued at $60,000 based on the common stock price at the date of grant. The Company recognized expense of $3,333 and $20,000 during the three months ended March 31, 2026 and 2025, respectively and expects to recognize an additional $32,222 through the end of the vesting period. Additionally, the consultant is eligible to receive an additional 750,000 shares of common stock based on performance benchmarks tied to certain revenue targets, with targets ranging from $5,000,000 to $50,000,000. These performance awards had a grant date fair value of $225,000. The Company recognized no expense during the three months ended March 31, 2026 and 2025 related to these awards as vesting was not deemed probable.

On February 11, 2026, the Board of Directors appointed Roy Milner ("Mr. Milner") to serve as an independent director of the Company, as defined under the applicable SEC rules and Nasdaq listing standards. On February 10, 2026, Mr. Milner and the Company entered into an Independent Director Agreement, with the following summarized terms:

Mr. Milner shall serve as an independent director of the Company and be available to perform the duties consistent with such position pursuant to the Certificate of Incorporation and Bylaws of the Company. Mr. Milner's employment commenced on February 10, 2026, and continues for a term of three (3) years.

Compensation that Mr. Milner will receive during his term includes the sum of $5,000, each calendar quarter, payable in the third month of each calendar quarter, and with such amount for any partial calendar quarter being appropriately prorated. Upon employment, the Company issued to Mr. Milner 100,000 shares of common stock with a fair value of $15,100 based on the closing price of the Company's common stock at the date of the agreement, subject to the terms and conditions of the Company's applicable equity incentive plan and any related grant documentation. The Company will also grant each calendar quarter of $10,000 in shares of Common Stock with shares divided by a VWAP schedule based on the 20 previous trading days. The Company is to issue an additional 46,546 shares of common stock with a fair value of $6,288 based on the closing price of the Company's common stock as of March 31, 2026. As of the date of this report, the Company has not issued the 46,546 shares of common stock to Mr. Milner.

The Company shall reimburse Mr. Milner for all reasonable out-of-pocket expenses incurred in the ordinary course of the Director's business, with out-of-pocket expenses of the Director in excess of $500 subject to preapproval in advance by the Company.

Mr. Milner is bound by certain confidentiality covenants with the Company. And has made certain representations and warranties customary to directors. According to the terms of the Independent Director Agreement, Mr. Milner shall relinquish all ownership to the Company, of work product related to his position with the Company, including any intellectual and proprietary rights of work product resulting from his position as director.

**NOTE 9 - RELATED PARTY TRANSACTIONS**

During the three months ended March 31, 2025, the Company received a total of $150,000 in proceeds from shareholders and repaid $55,500 of principal and $276 of accrued interest. The advances are unsecured, due on demand and have stated interests ranging from 10% to 12% per annum. As of March 31, 2026 and December 31, 2025, the balance owed on the advances from shareholders was $167,500. See Note 6 above.

**NOTE 10 – LEASES**

The Company maintains an operating lease for its office space and operating facility. The lease has a remaining term of 80 months. The Company determines if an arrangement is a lease at inception. As the rate implicit in each lease is not readily determinable, the Company uses its incremental borrowing rate based on information available at commencement to determine the present value of the lease payments. The Company used a weighted average incremental borrowing rate of 9.11% Right-of-use assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Leases with an initial term of 12 months or less ("short-term leases") are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. During the three months ended March 31, 2026, the Company renewed a facility lease for its Two Trees business for an additional three years and recognized an initial right of use asset and liability of $405,866.

As of March 31, 2026, the amount of right-of-use assets and lease liabilities were $976,100 and $1,008,242, respectively. As of December 31, 2025, the amount of right-of-use assets and lease liabilities were $628,125 and $661,109, respectively. Aggregate lease expense for the three months ended March 31, 2026, and 2025 was $78,473 and $79,725, respectively.

The following table provides the maturities of lease liabilities at March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
|  | | Operating Lease | Remaining <br>Term in Years |
| 2026 | (9 months remaining) | $238695 |  |
| 2027 |  | 324082 |  |
| 2028 |  | 333630 |  |
| 2029 |  | 204387 |  |
| 2030 |  | 92799 |  |
| thereafter |  |  |  |
| Total lease payments |  | 1193593 |  |
| Less: imputed interest |  | (185350) |  |
| Present value of lease liability |  | $1008242 | 3.75 |

---

**NOTE 11 – SEGMENT REPORTING**

The Company's operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) RF Specialties and (2) Two Trees Distilling. These segments are organized principally by product and service category. The Company's reportable segments are determined based on (1) financial information reviewed by the CODM, (2) operational structure of the Company which is designed and managed to share resources across the entire suite of products offered by the business, and (3) the basis upon which the CODM makes resource allocation decisions. The CODM for both segments is the Director, President and Chief Executive Officer of the Company. The CODM utilizes the segment operating income (loss) to assess profitability and performance of actual results compared to forecasts.

Significant segment expenses and assets information is as follows:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months ended**<br> **March 31,** | **For the Three Months ended**<br> **March 31,** |
|  | **2026** | **2025** |
| **Revenue** |  |  |
| Two Trees Distilling | $313739 | $252837 |
| RF Specialties | 120348 | 261093 |
| Total | $434087 | $513930 |
| **Cost of Sales** |  |  |
| Two Trees Distilling | $371051 | $168715 |
| RF Specialties | 199299 | 212683 |
| Total | $570350 | $381398 |
| **Gross profit** |  |  |
| Two Trees Distilling | $(57312) | $84122 |
| RF Specialties | (78951) | 48410 |
| Total | $(136263) | $132532 |
| **General & Administrative Expense** |  |  |
| Two Trees Distilling | $135892 | $145338 |
| RF Specialties | 43660 | 73670 |
| Corporate | 308342 | 364897 |
| Total | $487894 | $583905 |
| **Salary and Wages** |  |  |
| Two Trees Distilling | $- | $16148 |
| RF Specialties |  |  |
| Corporate | 146054 | 77661 |
| Total | $146054 | $93809 |
| **Depreciation and Amortization Expense** |  |  |
| Two Trees Distilling | $30570 | $24617 |
| RF Specialties | 33789 | 44885 |
| Corporate | 3242 | 3105 |
| Total | $67601 | $72607 |
| **Net loss from operations** |  |  |
| Two Trees Distilling | $(223774) | $(101981) |
| RF Specialties | (156400) | (70145) |
| Corporate | (457638) | (445663) |
| Total | $(837812) | $(617789) |
| **Capital expenditures** |  |  |
| Two Trees Distilling | $22202 | $571765 |
| RF Specialties | (35717) | 32612 |
| Total | $(13515) | $604377 |

---

---

| | | |
|:---|:---|:---|
| **Assets** | **As Of March 31, 2026** | **As of December 31, 2025** |
| Two Trees Distilling | $2705042 | $243519 |
| RF Specialties | 1268888 | 1233372 |
| Corporate | 197573 | 3498660 |
| Total | $4171503 | $4975551 |

---

**NOTE 12 - SUBSEQUENT EVENTS**

The Company has evaluated events occurring after the balance sheet date through the date these financial statements were issued. Based on management's assessment, no significant events were identified for the three-month period ended March 31, 2026.

On April 15, 2026, the Company entered into three convertible notes, two with members of the Board of Directors, and one with a family member of a Director, for an aggregate principal amount of $145,000 (the "Convertible Notes"). The Company received cash proceeds of $115,000 and settled $30,000 of accounts payable owed to a Director. The Convertible Notes bear interest at 20% per annum, payable monthly, mature on October 15, 2026 and are convertible beginning on the three month anniversary of issuance into common stock of the Company at a fixed price of $0.10 per share.

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**

*You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited interim condensed financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled "Risk Factors" included in this Quarterly Report on Form 10-Q, as may be amended, supplemented or superseded from time to time by other reports we file with the SEC. All amounts in this report are in U.S. dollars, unless otherwise noted.*

*Throughout this Quarterly Report on Form 10-Q, references to "we," "our," "us," the "Company," or "MDwerks," refer to MDwerks, Inc.*

**Overview**

MDwerks, Inc. (the "Company," "MDwerks," "we," "us," or "our"), a Delaware corporation, is a technology company pioneering the development of innovative energy wave solutions for industrial and other commercial enterprises. Our expertise in radio wave technologies and microwave technologies has led to multiple breakthroughs with applications both industrial and commercial. Our patented energy wave technology introduces a revolutionary approach to industrial processes by specific molecular targeting, which can be applied at precise and multiple locations in a system in ways that conventional single point heat sources cannot, resulting in improved efficiency, higher quality, and reduced processing time. In December 2023, we completed the acquisition of RF Specialties, LLC ("RFS") and Two Trees Beverage Co. and its subsidiaries ("Two Trees").

RFS, is engaged in the business of developing sustainable radio frequency ("RF") applications, and for over 14 years, has addressed a variety of challenges faced by companies by implementing automated radio frequency technology. One of these applications is a method for the rapid aging of distilled spirits using RF energy. This proprietary Spirits Rapid Aging System ("SRAS") reduces energy and production costs and increases the speed to market for distilled beverages when compared to traditional methods.

Our wholly-owned subsidiary, Two Trees Beverage Company, utilizes the SRAS, validating the use of this patented energy wave technology within the premium craft spirits industry. Our proprietary and patented molecular targeting system swiftly and sustainably transforms distillate to maturity, delivering traditional flavors in a fraction of the time with greatly reduced environmental impact and cost. Precision engineered to match traditional aging flavors and aromas, it has been used to produce over 50 SKUs and many award-winning products.

**Overview of the Business of RF Specialties**

RFS is engaged in the business of developing sustainable radio frequency (RF) applications, and for over 14 years, has addressed the challenges faced by companies by implementing automated radio frequency technology. RFS has developed a system and method for the rapid aging of distilled spirits with RF energy that reduces energy and production costs thus increasing the speed to market for distilled beverages when compared to traditional technologies.

Our patented energy wave technology introduces a revolutionary approach to industrial processes by specific molecular targeting, which can be applied at precise and multiple locations in a system in ways that conventional single point heat sources cannot, resulting in improved efficiency, higher quality, and reduced processing time.

The Company is currently deploying its first industrial application of our Molecular sawdust drying system with a lumber mill. The system offers scalable, flexible solutions for any tonnage of sawdust, catering to diverse pellet manufacturing needs. It utilizes patented technology to adjust moisture content as required, optimizing it to precise specifications. The system features precision automation for controlling temperature and drying parameters, ensuring consistent high-quality output. This adaptable system enhances safety and productivity, achieving uniform results with minimal downtime.

The Company is also targeting applications of this process in engineered wood products, adhesives, wood forest products and food and beverages.

**Overview of the Business of Two Trees**

Our Two Trees spirits business produces a variety of aged alcoholic beverages using our innovative rapid-aging system. This scalable technology results in all-natural, high-quality products, quickly and efficiently produced, with a reduced environmental impact. Our products are nearly indistinguishable from those that are traditionally aged.

Deep in Appalachian Mountain country, we created a proprietary process that mirrors and accelerates the natural aging process that occurs when alcohol is aged in wooden barrels over time. The true art of our craft spirits lives within the balance between the distillate selection, local water, and the full-bodied flavors from our wood chip varieties that are toasted to just the right char, bringing rich barrel flavor profiles to life.

**<u>Whiskey-as-a-Service</u>**

Among our accomplishments to start the year, we successfully launched our "Whiskey-as-a-Service" ("WaaS") business model, offering use of the SRAS through a flexible technology license structure to enable customers to access this transformative technology with minimal upfront investment, while securing long-term, predictable revenue streams for the Company. We also offer on-site aging of bulk spirits.

We have signed new contracts with two companies for the construction and deployment of our proprietary SRAS and see excellent potential for multiple additional SRAS deployments by both customers within the next twelve months as well as by other third parties.

The first of these units is anticipated to be installed on site at one of the largest distilleries in the U.S. in the second quarter of 2026, with the second unit deployed approximately three months thereafter. The second contract is with a leading U.S. wholesaler and broker of bulk spirits for one SRAS unit at their facility, which is estimated to be installed in the third quarter of 2026.

Under both contracts, RFS will manufacture and assemble the SRAS units and provide ongoing machine servicing and maintenance in addition to the recurring monthly license payments from the customers for use of the SRAS units.

These contracts validate the economic and sustainability benefits of our SRAS units and provide us with attractive recurring revenue streams through licensing agreements and ancillary fees for ongoing machine servicing and maintenance.

Building on the momentum of our first two WaaS contracts, we signed a separate new agreement with an international spirits investment fund (the "Fund") providing the Fund with limited exclusivity for the deployment of our SRAS units in three countries outside of the United States. To retain exclusivity, the Fund is required to deploy at least one SRAS unit annually in each of the three countries.

**Recent Developments**

Upgraded Capacity

In 2025, we began aging tanker loads of distillate at our facility for one of our SRAS customers to fill immediate demand for aged spirits. In early 2026, we completed installation of a higher capacity SRAS at our Two Trees facility in order to increase existing production across our aging services and brand production.

**Results of Operations**

**Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025**

---

| | | |
|:---|:---|:---|
|  | **For the Three Months ended**<br> **March 31,** | **For the Three Months ended**<br> **March 31,** |
|  | **2026** | **2025** |
| **Revenue** |  |  |
| Two Trees Distilling | $313739 | $252837 |
| RF Specialties | 120348 | 261093 |
| Total | $434087 | $513930 |
| **Cost of Sales** |  |  |
| Two Trees Distilling | $371051 | $168715 |
| RF Specialties | 199299 | 212683 |
| Total | $570350 | $381398 |
| **Gross profit** |  |  |
| Two Trees Distilling | $(57312) | $84122 |
| RF Specialties | (78951) | 48410 |
| Total | $(136263) | $132532 |

---

<u>Revenue.</u> Revenue for the three months ended March 31, 2026 was $434,087 compared to $513,930 for the three months ended March 31, 2025. Revenue of $313,739 for three months ending March,31, 2026 is attributable to the Two Trees business, compared to $252,837 in 2025, and $120,348 of revenue for three months ending March 31, 2026 attributable to product and service income from RFS, compared to $261,093 in 2025. The $60,092 increase revenue in the Two Trees business was primarily attributable to increased bulk alcohol sales in the current period which was partially offset by a decline in sales of RF Specialties of approximately $140,745 related to nearing completion on the MSD project and lower service revenue compared to the prior year.

In February 2025, the Company executed contracts with two customers related to the lease of an aggregate of three SRAS that are expected to begin producing revenue to the Company in the second half of 2025. The Company began building the machines for these customers in the first quarter, and we expect to drive significant growth in revenue and gross profit in our Two Trees Distilling business from this new revenue stream going forward.

<u>Cost of Sales.</u> Cost of sales for the three months ended March 31, 2026 was $570,350 compared to $381,398 for three months ended March 31, 2025. Cost of sales for the Company's Two Trees Distilling operations was $371,051 in 2026 compared to $168,715 in 2025, with the decline driven by higher input costs for our products, increase freight costs, and higher bulk alcohol sales. The Company's RF Specialties business incurred costs of sales of $199,299 in 2026 compared to $212,683 in 2025. The slight decrease was due to lower activity associated with the MSD project nearing completion.

<u>Operating Expenses</u>. We reported operating expenses of $701,549 consisting primarily of legal, accounting, payroll, and general business related expenses for the three months ended March 31, 2026 compared to $750,321 for the three months ended March 31, 2025. The $122,801 decrease in operating expenses was primarily attributable to decreased general and administrative expense. Selling, general and administrative expenses was $467,366 and $583,905 for the three months ended March 31, 2026 and 2025, respectively, and included legal, accounting and audit fees related to our public company reporting obligations, stock-based compensation of $44,891 and $66,322, respectively due to new equity awards to employees and consultants in the prior year. Operating expenses also included salary and wages expense of $146,054 and $93,809 for the three months ended March 31, 2026 and 2025, respectively. Operating expenses included depreciation and amortization expense of $67,601 and $72,607 for the three months ended March 31, 2026 and 2025, respectively.

<u>Total Other Expenses</u>. Total other expense was $9,220 for the three months ended March 31, 2026 compared to $11,565 for the three months ended March 31, 2025. Other expense for the three months ended March 31, 2026 primarily consisted of interest expense of $9,220. Other expense for the three months ended March 31, 2025 primarily consisted of interest expense of $11,765 and interest income of $200

**Liquidity and Capital Resources**

As of March 31, 2026, and December 31, 2025, we had $95,754 and $211,948 of cash, respectively. We anticipate that our current cash and cash generated from financing activities will be insufficient to satisfy our liquidity requirements for the next 12 months. As of March 31, 2026, we have incurred operating losses since inception of $7,005,527. At March 31, 2026, we had a working capital deficit of $1,782,901.

We believe that if we do not raise additional capital over the next 12 months, we may be required to suspend or cease the implementation of our business plans. We require additional funding to meet our ongoing obligations and to fund anticipated operating losses. Management has expressed substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent on raising capital to fund our initial business plan and ultimately to attain profitable operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

We expect to incur marketing, professional, and administrative expenses as well expenses associated with maintaining our filings with the Commission. We will require additional funds during this time and will seek to raise the necessary additional capital. During the three months ended, we raised $450,000 in cash proceeds from the sale of common stock. If we are unable to obtain additional financing, we may be required to reduce the scope of our business development activities, which could harm our business plans, financial condition and operating results. Additional funding may not be available on favorable terms, if at all. We intend to continue to fund our business by way of equity or debt financing and advances from related parties. Any inability to raise capital as needed would have a material adverse effect on our business, financial condition and results of operations.

***Cash Flows***

**Cash Used in Operating Activities.** Net cash used in operating activities for the three months ended March 31, 2026 and 2025 were $464,418 and $421,316. The increase was attributable to an increase in net loss compared to the prior year as a result of increased operating expenses associated with the new businesses as described above.

**Cash Used from Investing Activities.** Cash used in investing activities for the three months ended March 31, 2026 and 2025 was $62,907 and $604,377, respectively, with higher costs in the prior year associated with construction of the Company's new SRAS equipment, deployed in the first quarter of 2026.

**Cash Provided by Financing Activities.** Net cash provided by financing activities for the three months ended March 31, 2026 and 2025 was $411,131 and $1,607,709, respectively. The cash provided by financing activities for the three months ended March 31, 2026 was attributable to proceeds from the sale of common stock of $450,000, including subscription payable of $205,000, partially offset by repayments of notes payable of $38,869. The cash provided by financing activities for the three months ended March 31, 2025 was attributable to proceeds from the sale of common stock of $1,434,000, including subscription payable of $150,000, proceeds from related party notes payable of $150,000, partially offset by repayments of notes payable of $126,291.

**Off-Balance Sheet Arrangements**

There are no off-balance sheet arrangements currently contemplated by management or in place that are reasonably likely to have a current or future effect on the business, financial condition, changes in financial condition, revenue or expenses, result of operations, liquidity, capital expenditures and/or capital resources.

**Recent Accounting Standards**

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (DISE), requiring additional disclosure of the nature of expenses included in the income statement. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of our pending adoption of this standard on our consolidated financial statements.

We have implemented all new accounting standards that are in effect and that may impact our financial statements and do not believe that there are any other new accounting standards that have been issued that might have a material impact on its financial position or results of operations.

**Critical Accounting Policies and Estimates**

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may vary under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Our management believes the accounting policies below are critical in the portrayal of our financial condition and results of operations and require management's most difficult, subjective, or complex judgments.

**Revenue Recognition**

Net sales from Two Trees include liquor and related products, less excise taxes and customer programs and incentives. Sales from RFS include product and services related to sustainable Radio Frequency applications to a wide range of industries including structural engineering, food & beverage, and manufacturing. We recognize revenue by applying the following steps in accordance with ASC Topic 606 - Revenue from Contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

We recognize sales when merchandise is shipped from a warehouse directly to wholesale customers (except in the case of a consignment sale). For consignment sales, which include sales to the Oregon Liquor Control Commission, we recognize sales upon the consignee's shipment to the customer. Postage and handling charges billed to customers are also recognized as sales upon shipment of the related merchandise. Shipping terms are generally FOB shipping point, and title passes to the customer at the time and place of shipment or purchase by customers at a retail location. For consignment sales, title passes to the consignee concurrent with the consignee's shipment to the customer. The customer has no cancellation privileges after shipment or upon purchase at retail locations, other than customary rights of return. For service revenue within our radio frequency applications, we recognize revenue as the services are provided to the customer over the length of the contract. Our contracts typically have a single performance obligation, and do not contain a significant financing component.

**Goodwill** - Goodwill represents the excess of acquisition cost over the fair value of the net tangible and intangible assets acquired. Goodwill is not amortized and is subject to annual impairment testing on or between annual tests if an event or change in circumstance occurs that would more likely than not reduce the fair value of a reporting unit below its carrying value. In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it can conclude the assessment. If we conclude otherwise, we are required to perform a quantitative analysis to determine the amount of impairment. A quantitative analysis is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value to determine the amount of impairment, if any. We have determined that we have two reporting units.

**Impairment of Long-Lived Assets** - Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair market value of the assets.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

**Item 4. Controls and Procedures.**

*Disclosure Controls and Procedures*

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act") is recorded, processed, summarized and reported, within the time period specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

The Company's principal executive officer and principal financial officer have evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2026. Based upon such evaluation, the principal executive officer and principal financial officer have concluded that, as of March 31, 2026, our disclosure controls and procedures were not effective as required under Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

*Changes in Internal Control Over Financial Reporting*

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

**PART II-OTHER INFORMATION**

**Item 1. Legal Proceedings.**

None.

**Item 1A. Risk Factors.**

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

**Item 2. Unregistered Sales of Securities and Use of Proceeds.**

The following information represents securities sold by us that has not been previously included in a Quarterly Report on Form 10-Q or a Current Report of Form 8-K which were not registered under the Securities Act. Included are new issues, securities issued in exchange for property, services or other securities, securities issued upon conversion from our other share classes and new securities resulting from the modification of outstanding securities. We issued all of the securities listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act (the "Securities Act"), or Regulation D or Regulation S promulgated thereunder.

During the three months ended March 31, 2026, we sold 2,833,333 shares of common stock in exchange for cash proceeds of $450,000, of which 2,500,000 shares are not yet issued.

**Item 3. Defaults Upon Senior Securities.**

None

**Item 4. Mine Safety Disclosure.**

None

**Item 5. Other Information.**

(a) None.

(b) There have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors since we last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

(c) During the quarter ended March 31, 2026, no director or officer adopted or terminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or a non-Rule 10b5-1 trading arrangement.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit No.** | **Descriptio**n |
| 10.1\* | [Convertible Promissory Note between the Company and Timothy Brocopp dated April 15, 2026](ex10-1.htm) |
| 10.2\* | [Convertible Promissory Note between the Company and Keggan Brocopp dated April 15, 2026](ex10-2.htm) |
| 10.3\* | [Convertible Promissory Note between the Company and Richard Blackstone dated April 15, 2026](ex10-3.htm) |
| 10.4\* | [Convertible Promissory Note between the Company and Joshua Blackstone dated April 15, 2026](ex10-4.htm) |
| 31.1\* | [Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act](ex31-1.htm) |
| 31.2\* | [Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act](ex31-2.htm) |
| 32.1\*\* | [Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](ex32-1.htm) |
| 32.2\*\* | [Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](ex32-2.htm) |
| 101.INS\* | Inline XBRL Instance Document |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104\* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| \* | Filed herewith. |
| \*\* | Furnished herewith. |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | **MDwerks, Inc.** |
| Date: May 15, 2026 | */s/ Steven C. Laker* |
|  | Steven C. Laker |
|  | Chief Executive Officer and Chief Financial Officer |
|  | (Principal Executive Officer) |
| Date: May 15, 2026 | */s/ David Stephens* |
|  | David Stephens |
|  | Chief Financial Officer |
|  | (Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 10.1

**Exhibit 10.1**

**CONVERTIBLE PROMISSORY NOTE**

**NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$75000.00 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 15, 2026 |

---

**FOR VALUE RECEIVED**, MDWerks., Inc. a Delaware Corporation (the "Borrower"), hereby promises to pay to the order of <u>Tim Brocopp</u> (the "Lender"), the principal sum of $75,000.00 (seventy-five thousand) or, if less *the* aggregate unpaid amount of all advances made by the Lender to the Borrower, together with interest, at a rate of 1.67% per month, (20% annually). This Note shall be due and payable, together with accrued but unpaid interest hereon, on October 15, 2026, or as otherwise agreed to in writing by the Borrower and Lender. The Value Received noted above consisted of $75,000 in cash paid to the Borrower by the Lender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **Repayment.** All Payments shall be applied, on a *pro rata* basis among outstanding advances,
 first to interest and then to the unpaid principal of this note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Borrower
 may prepay this Note in whole or in part at any time without penalty. Any and all prepayments
 shall be credited first to accrued interest on this Note to the date of the prepayment, on
 a *pro rata* basis among outstanding advances or to specific advances as designated
 by the Borrower, and then to the unpaid principal of this Note on *pro rata* basis among
 outstanding advances or to specific advances as designated by the Borrower.

b. Borrower
 waives diligence, demand, presentment of payment, notice of nonpayment, protest and notice
 of protest, and notice of any renewals or extensions of this Note and agrees that the time
 for payment of this Note may be extended at Lender's sole discretion without impairing
 its liability thereon. Any delay on the part of the Lender in exercising any right hereunder
 shall not operate as a waiver of any such right, and any waiver granted for one occasion
 shall not operate as a waiver in the event of any subsequent default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **Conversion Right.** The Holder shall have the right at any time commencing on the three month anniversary
 date of this Note, until this Note is fully paid, to convert any outstanding and unpaid principal
 portion of this Note, and accrued interest, at the election of the Holder (the date of giving
 of such notice of conversion being a "Conversion Date") into fully paid and nonassessable
 shares of $0.001 par value common stock of the Borrower ("Common Stock"). Subject
 to adjustment as provided below, the conversion price ("Conversion Price") per
 share shall be a price equal to $0.10 (ten cents) per share of the Company's Common
 Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. In
 no event shall the Holder be entitled to convert any portion of this Note in excess of that
 portion of this Note upon conversion of which the sum of (1) the number of shares of Common
 Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock
 which may be deemed beneficially owned through the ownership of the unconverted portion of
 the Notes or the unexercised or unconverted portion of any other security of the Borrower
 subject to a limitation on conversion or exercise analogous to the limitations contained
 herein) and (2) the number of shares of Common Stock issuable upon the conversion of the
 portion of this Note with respect to which the determination of this proviso is being made,
 would result in beneficial ownership by the Holder and its affiliates of more than 4.99%
 of the outstanding shares of Common Stock. For purposes of the proviso to the immediately
 preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d)
 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
 Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <u>The beneficial ownership limitations on conversion as set forth in the section may NOT be waived by the Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Upon
 delivery to the Borrower of a completed Notice of Conversion, a form of which is annexed
 hereto as Schedule A, Borrower shall issue and deliver to the Holder within five (5) business
 days after the Conversion Date (such fifth day being the "Delivery Date") that
 number of shares of Common Stock for the portion of the Note converted in accordance with
 the foregoing. The Holder will not be required to surrender the Note to the Borrower until
 the Note has been fully converted or satisfied. The number of shares of Common Stock to be
 issued upon each conversion of this Note shall be determined by dividing that portion of
 the principal of the Note and interest, if any, to be converted, by the Conversion Price.

c. If
 the Borrower at any time shall, by reclassification or otherwise, change the Common Stock
 into the same or a different number of securities of any class or classes that may be issued
 or outstanding, this Note, as to the unpaid principal portion thereof and accrued interest
 thereon, shall thereafter be deemed to evidence the right to purchase an adjusted number
 of such securities and kind of securities as would have been issuable as the result of such
 change with respect to the Common Stock immediately prior to such reclassification or other
 change.

d. If
 the shares of Common Stock are subdivided or combined into a greater or smaller number of
 shares of Common Stock, or if a dividend is paid on the Common Stock in shares of Common
 Stock, the Conversion Price shall be proportionately reduced in case of subdivision of shares
 or stock dividend or proportionately increased in the case of combination of shares, in each
 such case by the ratio which the total number of shares of Common Stock outstanding immediately
 after such event bears to the total number of shares of Common Stock outstanding immediately
 prior to such event. This Note shall bind the successors and assigns of the Borrower and
 shall injure to the benefit of the Lender, its successors and assigns. At the Borrower's
 discretion any outstanding advance may be converted to equity in the Company.

e. Whenever
 the Conversion Price is adjusted pursuant to the events above, the Borrower shall promptly
 but not later than the fifth (5th) business day after the effectiveness of the adjustment,
 provide notice to the Holder setting forth the Conversion Price after such adjustment and
 setting forth a statement of the facts requiring such adjustment. Failure to provide the
 foregoing notice is an Event of Default under this Note.

f. This
 Note may be converted by the Holder in whole or in part as described in Section 2.1(a) hereof.
 Upon partial conversion of this Note, a new Note containing the same date and provisions
 of this Note shall, at the request of the Holder, be issued by the Borrower to the Holder
 for the principal balance of this Note and interest which shall not have been converted or
 paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **Events of Default**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Events
 of Default. If any one or more of the following events ("Events of Default")
 shall occur and be continuing (and whether such occurrence shall be voluntary or involuntary
 or come about or be effected by operation of law or pursuant to or in compliance with any
 judgment, decree, or order of any court or any order, rule, or regulation of any administrative
 or governmental body), the Lender may, at its option, declare the Note to be immediately
 due and payable, whereupon the maturity of the then unpaid balance of the Note shall be accelerated
 and the same, together with all interest accrued thereon, shall forthwith become due and
 payable without presentment, demand, protest, or notice of any kind, all of which are hereby
 expressly waived, anything contained herein or in the Note to the contrary notwithstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. If
 default shall be made in the due and punctual payment of the principal or interest under
 the Note, when and as the same shall become due and payable, whether at maturity, by acceleration,
 or otherwise;

ii. If
 default shall be made in the performance or observance of, or shall occur under, any covenant,
 agreement, or other provision of this Agreement or in any instrument or document delivered
 to the Lender in connection with or pursuant to this Agreement, or if any such instrument
 or document shall terminate or become void or unenforceable without the written consent of
 the Lender;

iii. If
 default shall occur in the payment of any principal, interest, or other amount due with respect
 to any indebtedness for borrowed money, subordinated debt or other debt of the Borrower or
 under any agreement or instrument under or pursuant to which any such indebtedness, subordinated
 debt, or other debt may have been issued, created, assumed, or guaranteed by the Borrower
 and such default shall continue for more than the grace period, if any, therein specified,
 or if any such indebtedness, subordinated debt, or other debt be declared due and payable
 prior to the stated maturity thereof;

iv. If
 any representation or warranty or any other statement of fact herein or in any writing, certificate,
 report, or statement at any time furnished to the Lender pursuant to or in connection with
 this Agreement, or otherwise, shall be false or misleading in any material respect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. If the Borrower shall admit in writing its inability to pay its debts generally as they become
 due, file a petition in bankruptcy or a petition to take advantage of any insolvency act;
 make an assignment for the benefit of creditors; commence a proceeding for the appointment
 of a receiver, trustee, liquidator, or conservator of itself or of a whole or any substantial
 part of its property; file a petition or answer seeking reorganization or arrangement or
 similar relief under the United States federal bankruptcy laws or any similar law or statute
 of any state or country;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. If
 the Borrower shall be adjudged a bankrupt; or a court of competent jurisdiction shall enter
 an order, judgment, or decree appointing a receiver, trustee, liquidator, or conservator
 of the Borrower or of the whole or any substantial part of its property, or approve a petition
 filed against the Borrower seeking reorganization or similar relief under the United States
 federal bankruptcy laws or any similar law or statute of any state or country, or if, under
 the provisions of any other law for the relief or aid of debtors, a court of competent jurisdiction
 shall assume custody or control of the Borrower or of the whole or any substantial part of
 its property; or if there is commenced against the Borrower any proceeding for any of the
 foregoing relief or if a petition in bankruptcy is filed against the Borrower and such proceeding
 or petition remains undismissed or unstayed for a period of ninety (90) days; or if the Borrower
 by any act indicates its consent to, approval of or acquiescence in any such proceeding or
 petition; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. **Suits for Enforcement.** If any one or more Events of Default shall occur and be continuing,
 the Lender may proceed to protect and enforce its rights or remedies either by suit in equity
 or by action at law, or both, whether for the specific performance of any covenant, agreement
 or other provision contained herein, in the Note, or in any document or instrument delivered
 in connection with or pursuant to this Agreement, or to enforce the payment of the Note or
 any other legal or equitable right or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. **Rights and Remedies Cumulative**. No right or remedy herein conferred upon the Lender is intended
 to be exclusive of any other right or remedy contained herein, in the Note, or in any instrument
 or document delivered in connection with or pursuant to this Agreement, and every such right
 or remedy shall be cumulative and shall be in addition to every other such right or remedy
 contained herein and therein or now or hereafter existing at law or in equity or by statute,
 or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. **Rights and Remedies Not Waived**. No course of dealing between the Borrower and the Lender or any failure or delay on the part of the Lender
in exercising any rights or remedies hereunder shall operate as a waiver of any rights or remedies of the Lender and no single or partial
exercise of any rights or remedies hereunder shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **Modification and Waiver**. No modification or waiver of any provision of the Note or of this Agreement
 and no consent by the Lender to any departure therefrom by the Borrower shall be effective
 unless such modification or waiver shall be in writing and signed by the Lender, and the
 same shall then be effective only for the period, on the conditions and for the specific
 instances and purposes specified in such writing. No notice to or demand on the Borrower
 in any case shall entitle the Borrower to any other or further notice or demand in similar
 or other circumstances.

5. **Corporate Obligation.** It is expressly understood that this Note is a corporate obligation of MDWerks,
 Inc., and is not guaranteed by any stockholder, officer or employee of MDWerks, Inc., and
 the Lender agrees to indemnify all stockholders, officers and employees of MDWerks, Inc.,
 for any and all obligations and liabilities associated with this Note.

6. **Benefit of Agreement**. This Agreement shall be binding upon and inure to the benefit of the Borrower
 and the Lender and their successors and assigns, and all subsequent holders of the Note.

7. **Notices.** All notices, requests, demands, or other communications provided for herein shall be in writing
 and shall be deemed to have been given when sent by registered or certified mail, return
 receipt requested, addressed to the parties, at the addresses set forth above, or to such
 other address as either party shall designate to the other from time to time in writing forwarded
 in like manner.

8. **Captions.** The captions of the various sections and paragraphs of this Agreement have been inserted
 only for the purposes of convenience; such captions are not a part of this Agreement and
 shall not be deemed in any manner to modify, explain, enlarge, or restrict any of the provisions
 of this Agreement.

9. **Applicable Law** This Note shall be governed by and construed in accordance with the laws of the State
 of Delaware, without giving effect to the laws, rules or principles of such State, regarding
 conflicts of laws. The Borrower and Lender each agree to the jurisdiction of the state and
 federal courts within the State of Delaware.

10. **Execution in Counterparts**. This Agreement may be executed in counterparts, all of which taken together
 shall be deemed one original.

[The remainder of this page has been intentionally left blank. Signature page follows.]

IN WITNESS WHEREOF, the parties hereto have set their hands and seals as of the day and year first set forth above.

---

| | |
|:---|:---|
| **BORROWER:** | **BORROWER:** |
| **MDWerks, Inc.** | **MDWerks, Inc.** |
| By: | /s/ Steven Laker |
| Its: | CEO |
| **LENDER:** | **LENDER:** |
|  | **Tim Brocopp** |
| By: | /s/ Tim Brocopp |
| An Individual | An Individual |

---

**<u>SCHEDULE A - NOTICE OF CONVERSION</u>**

(To be executed by the Registered Holder in order to convert the Note)

The undersigned hereby elects to convert $_________ of the principal and $_________ of the interest due on the Note issued by MDWERKS, INC. on ________ ___into Shares of Common Stock of MDWerks Inc. (the "Borrower") according to the conditions set forth in such Note, as of the date written below.

Date of Conversion:____________________________________________________________________

Conversion Price:______________________________________________________________________

Shares To Be Delivered:_________________________________________________________________

Signature:____________________________________________________________________________

Print Name:__________________________________________________________________________

Address:_____________________________________________________________________________

___________________________________________________________________________

## Exhibit 10.2

**Exhibit 10.2**

**CONVERTIBLE PROMISSORY NOTE**

**NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$25000.00 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 15, 2026 |

---

**FOR VALUE RECEIVED**, MDWerks., Inc. a Delaware Corporation (the "Borrower"), hereby promises to pay to the order of <u>Keggan Brocopp</u> (the "Lender"), the principal sum of $25,000.00 (twenty-five thousand) or, if less *the* aggregate unpaid amount of all advances made by the Lender to the Borrower, together with interest, at a rate of 1.67% per month, (20% annually). This Note shall be due and payable, together with accrued but unpaid interest hereon, on October 15, 2026, or as otherwise agreed to in writing by the Borrower and Lender. The Value Received noted above consisted of $25,000 in cash paid to the Borrower by the Lender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **Repayment.** All Payments shall be applied, on a *pro rata* basis among outstanding advances,
 first to interest and then to the unpaid principal of this note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Borrower
 may prepay this Note in whole or in part at any time without penalty. Any and all prepayments
 shall be credited first to accrued interest on this Note to the date of the prepayment, on
 a *pro rata* basis among outstanding advances or to specific advances as designated
 by the Borrower, and then to the unpaid principal of this Note on *pro rata* basis among
 outstanding advances or to specific advances as designated by the Borrower.

b. Borrower
 waives diligence, demand, presentment of payment, notice of nonpayment, protest and notice
 of protest, and notice of any renewals or extensions of this Note and agrees that the time
 for payment of this Note may be extended at Lender's sole discretion without impairing
 its liability thereon. Any delay on the part of the Lender in exercising any right hereunder
 shall not operate as a waiver of any such right, and any waiver granted for one occasion
 shall not operate as a waiver in the event of any subsequent default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **Conversion Right.** The Holder shall have the right at any time commencing on the three month anniversary
 date of this Note, until this Note is fully paid, to convert any outstanding and unpaid principal
 portion of this Note, and accrued interest, at the election of the Holder (the date of giving
 of such notice of conversion being a "Conversion Date") into fully paid and nonassessable
 shares of $0.001 par value common stock of the Borrower ("Common Stock"). Subject
 to adjustment as provided below, the conversion price ("Conversion Price") per
 share shall be a price equal to $0.10 (ten cents) per share of the Company's Common
 Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. In
 no event shall the Holder be entitled to convert any portion of this Note in excess of that
 portion of this Note upon conversion of which the sum of (1) the number of shares of Common
 Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock
 which may be deemed beneficially owned through the ownership of the unconverted portion of
 the Notes or the unexercised or unconverted portion of any other security of the Borrower
 subject to a limitation on conversion or exercise analogous to the limitations contained
 herein) and (2) the number of shares of Common Stock issuable upon the conversion of the
 portion of this Note with respect to which the determination of this proviso is being made,
 would result in beneficial ownership by the Holder and its affiliates of more than 4.99%
 of the outstanding shares of Common Stock. For purposes of the proviso to the immediately
 preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d)
 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
 Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <u>The beneficial ownership limitations on conversion as set forth in the section may NOT be waived by the Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Upon
 delivery to the Borrower of a completed Notice of Conversion, a form of which is annexed
 hereto as Schedule A, Borrower shall issue and deliver to the Holder within five (5) business
 days after the Conversion Date (such fifth day being the "Delivery Date") that
 number of shares of Common Stock for the portion of the Note converted in accordance with
 the foregoing. The Holder will not be required to surrender the Note to the Borrower until
 the Note has been fully converted or satisfied. The number of shares of Common Stock to be
 issued upon each conversion of this Note shall be determined by dividing that portion of
 the principal of the Note and interest, if any, to be converted, by the Conversion Price.

c. If
 the Borrower at any time shall, by reclassification or otherwise, change the Common Stock
 into the same or a different number of securities of any class or classes that may be issued
 or outstanding, this Note, as to the unpaid principal portion thereof and accrued interest
 thereon, shall thereafter be deemed to evidence the right to purchase an adjusted number
 of such securities and kind of securities as would have been issuable as the result of such
 change with respect to the Common Stock immediately prior to such reclassification or other
 change.

d. If
 the shares of Common Stock are subdivided or combined into a greater or smaller number of
 shares of Common Stock, or if a dividend is paid on the Common Stock in shares of Common
 Stock, the Conversion Price shall be proportionately reduced in case of subdivision of shares
 or stock dividend or proportionately increased in the case of combination of shares, in each
 such case by the ratio which the total number of shares of Common Stock outstanding immediately
 after such event bears to the total number of shares of Common Stock outstanding immediately
 prior to such event. This Note shall bind the successors and assigns of the Borrower and
 shall injure to the benefit of the Lender, its successors and assigns. At the Borrower's
 discretion any outstanding advance may be converted to equity in the Company.

e. Whenever
 the Conversion Price is adjusted pursuant to the events above, the Borrower shall promptly
 but not later than the fifth (5th) business day after the effectiveness of the adjustment,
 provide notice to the Holder setting forth the Conversion Price after such adjustment and
 setting forth a statement of the facts requiring such adjustment. Failure to provide the
 foregoing notice is an Event of Default under this Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. This
 Note may be converted by the Holder in whole or in part as described in Section 2.1(a) hereof.
 Upon partial conversion of this Note, a new Note containing the same date and provisions
 of this Note shall, at the request of the Holder, be issued by the Borrower to the Holder
 for the principal balance of this Note and interest which shall not have been converted or
 paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **Events of Default**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Events
 of Default. If any one or more of the following events ("Events of Default")
 shall occur and be continuing (and whether such occurrence shall be voluntary or involuntary
 or come about or be effected by operation of law or pursuant to or in compliance with any
 judgment, decree, or order of any court or any order, rule, or regulation of any administrative
 or governmental body), the Lender may, at its option, declare the Note to be immediately
 due and payable, whereupon the maturity of the then unpaid balance of the Note shall be accelerated
 and the same, together with all interest accrued thereon, shall forthwith become due and
 payable without presentment, demand, protest, or notice of any kind, all of which are hereby
 expressly waived, anything contained herein or in the Note to the contrary notwithstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. If
 default shall be made in the due and punctual payment of the principal or interest under
 the Note, when and as the same shall become due and payable, whether at maturity, by acceleration,
 or otherwise;

ii. If
 default shall be made in the performance or observance of, or shall occur under, any covenant,
 agreement, or other provision of this Agreement or in any instrument or document delivered
 to the Lender in connection with or pursuant to this Agreement, or if any such instrument
 or document shall terminate or become void or unenforceable without the written consent of
 the Lender;

iii. If
 default shall occur in the payment of any principal, interest, or other amount due with respect
 to any indebtedness for borrowed money, subordinated debt or other debt of the Borrower or
 under any agreement or instrument under or pursuant to which any such indebtedness, subordinated
 debt, or other debt may have been issued, created, assumed, or guaranteed by the Borrower
 and such default shall continue for more than the grace period, if any, therein specified,
 or if any such indebtedness, subordinated debt, or other debt be declared due and payable
 prior to the stated maturity thereof;

iv. If
 any representation or warranty or any other statement of fact herein or in any writing, certificate,
 report, or statement at any time furnished to the Lender pursuant to or in connection with
 this Agreement, or otherwise, shall be false or misleading in any material respect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. If the Borrower shall admit in writing its inability to pay its debts generally as they become
 due, file a petition in bankruptcy or a petition to take advantage of any insolvency act;
 make an assignment for the benefit of creditors; commence a proceeding for the appointment
 of a receiver, trustee, liquidator, or conservator of itself or of a whole or any substantial
 part of its property; file a petition or answer seeking reorganization or arrangement or
 similar relief under the United States federal bankruptcy laws or any similar law or statute
 of any state or country;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. If
 the Borrower shall be adjudged a bankrupt; or a court of competent jurisdiction shall enter
 an order, judgment, or decree appointing a receiver, trustee, liquidator, or conservator
 of the Borrower or of the whole or any substantial part of its property, or approve a petition
 filed against the Borrower seeking reorganization or similar relief under the United States
 federal bankruptcy laws or any similar law or statute of any state or country, or if, under
 the provisions of any other law for the relief or aid of debtors, a court of competent jurisdiction
 shall assume custody or control of the Borrower or of the whole or any substantial part of
 its property; or if there is commenced against the Borrower any proceeding for any of the
 foregoing relief or if a petition in bankruptcy is filed against the Borrower and such proceeding
 or petition remains undismissed or unstayed for a period of ninety (90) days; or if the Borrower
 by any act indicates its consent to, approval of or acquiescence in any such proceeding or
 petition; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. **Suits for Enforcement.** If any one or more Events of Default shall occur and be continuing,
 the Lender may proceed to protect and enforce its rights or remedies either by suit in equity
 or by action at law, or both, whether for the specific performance of any covenant, agreement
 or other provision contained herein, in the Note, or in any document or instrument delivered
 in connection with or pursuant to this Agreement, or to enforce the payment of the Note or
 any other legal or equitable right or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. **Rights and Remedies Cumulative**. No right or remedy herein conferred upon the Lender is intended
 to be exclusive of any other right or remedy contained herein, in the Note, or in any instrument
 or document delivered in connection with or pursuant to this Agreement, and every such right
 or remedy shall be cumulative and shall be in addition to every other such right or remedy
 contained herein and therein or now or hereafter existing at law or in equity or by statute,
 or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. **Rights and Remedies Not Waived.** No course of dealing between the Borrower and the Lender or any failure or delay on the part of the Lender
in exercising any rights or remedies hereunder shall operate as a waiver of any rights or remedies of the Lender and no single or partial
exercise of any rights or remedies hereunder shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **Modification and Waiver**. No modification or waiver of any provision of the Note or of this Agreement
 and no consent by the Lender to any departure therefrom by the Borrower shall be effective
 unless such modification or waiver shall be in writing and signed by the Lender, and the
 same shall then be effective only for the period, on the conditions and for the specific
 instances and purposes specified in such writing. No notice to or demand on the Borrower
 in any case shall entitle the Borrower to any other or further notice or demand in similar
 or other circumstances.

5. **Corporate Obligation.** It is expressly understood that this Note is a corporate obligation of MDWerks,
 Inc., and is not guaranteed by any stockholder, officer or employee of MDWerks, Inc., and
 the Lender agrees to indemnify all stockholders, officers and employees of MDWerks, Inc.,
 for any and all obligations and liabilities associated with this Note.

6. **Benefit of Agreement**. This Agreement shall be binding upon and inure to the benefit of the Borrower
 and the Lender and their successors and assigns, and all subsequent holders of the Note.

7. **Notices.** All notices, requests, demands, or other communications provided for herein shall be in writing
 and shall be deemed to have been given when sent by registered or certified mail, return
 receipt requested, addressed to the parties, at the addresses set forth above, or to such
 other address as either party shall designate to the other from time to time in writing forwarded
 in like manner.

8. **Captions.** The captions of the various sections and paragraphs of this Agreement have been inserted
 only for the purposes of convenience; such captions are not a part of this Agreement and
 shall not be deemed in any manner to modify, explain, enlarge, or restrict any of the provisions
 of this Agreement.

9. **Applicable Law** This Note shall be governed by and construed in accordance with the laws of the State
 of Delaware, without giving effect to the laws, rules or principles of such State, regarding
 conflicts of laws. The Borrower and Lender each agree to the jurisdiction of the state and
 federal courts within the State of Delaware.

10. **Execution in Counterparts**. This Agreement may be executed in counterparts, all of which taken together
 shall be deemed one original.

[The remainder of this page has been intentionally left blank. Signature page follows.]

IN WITNESS WHEREOF, the parties hereto have set their hands and seals as of the day and year first set forth above.

---

| | |
|:---|:---|
| **BORROWER:** | **BORROWER:** |
| **MDWerks, Inc.** | **MDWerks, Inc.** |
| By: | /s/ Steven Laker |
| Its: | CEO |
| **LENDER:** | **LENDER:** |
|  | **Keggan Brocopp** |
| By: | /s/ Keggan Brocopp |
| An Individual | An Individual |

---

**<u>SCHEDULE A - NOTICE OF CONVERSION</u>**

(To be executed by the Registered Holder in order to convert the Note)

The undersigned hereby elects to convert $_________ of the principal and $_________ of the interest due on the Note issued by MDWERKS, INC. on ________ ___into Shares of Common Stock of MDWerks Inc. (the "Borrower") according to the conditions set forth in such Note, as of the date written below.

Date of Conversion:____________________________________________________________________

Conversion Price:______________________________________________________________________

Shares To Be Delivered:_________________________________________________________________

Signature:____________________________________________________________________________

Print Name:__________________________________________________________________________

Address:_____________________________________________________________________________

___________________________________________________________________________

## Exhibit 10.3

**Exhibit 10.3**

**CONVERTIBLE PROMISSORY NOTE**

**NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$30000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 15, 2026 |

---

**FOR VALUE RECEIVED**, MDWerks., Inc. a Delaware Corporation (the "Borrower"), hereby promises to pay to the order of <u>Richard Blackstone</u> (the "Lender"), the principal sum of $30,000 (thirty thousand dollars) or, if less *the* aggregate unpaid amount of all advances made by the Lender to the Borrower, together with interest, at a rate of 1.67% per month, (20% annually). This Note shall be due and payable, together with accrued but unpaid interest hereon, on October 15, 2026, or as otherwise agreed to in writing by the Borrower and Lender. The Value Received noted above consisted of the exchange of $30,000 in accounts payable owed to the Lender by the Borrower.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **Repayment.** All Payments shall be applied, on a *pro rata* basis among outstanding advances,
 first to interest and then to the unpaid principal of this note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Borrower
 may prepay this Note in whole or in part at any time without penalty. Any and all prepayments
 shall be credited first to accrued interest on this Note to the date of the prepayment, on
 a *pro rata* basis among outstanding advances or to specific advances as designated
 by the Borrower, and then to the unpaid principal of this Note on *pro rata* basis among
 outstanding advances or to specific advances as designated by the Borrower.

b. Borrower
 waives diligence, demand, presentment of payment, notice of nonpayment, protest and notice
 of protest, and notice of any renewals or extensions of this Note and agrees that the time
 for payment of this Note may be extended at Lender's sole discretion without impairing
 its liability thereon. Any delay on the part of the Lender in exercising any right hereunder
 shall not operate as a waiver of any such right, and any waiver granted for one occasion
 shall not operate as a waiver in the event of any subsequent default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **Conversion Right.** The Holder shall have the right at any time commencing on the three month anniversary
 date of this Note, until this Note is fully paid, to convert any outstanding and unpaid principal
 portion of this Note, and accrued interest, at the election of the Holder (the date of giving
 of such notice of conversion being a "Conversion Date") into fully paid and nonassessable
 shares of $0.001 par value common stock of the Borrower ("Common Stock"). Subject
 to adjustment as provided below, the conversion price ("Conversion Price") per
 share shall be a price equal to $0.10 (ten cents) per share of the Company's Common
 Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. In
 no event shall the Holder be entitled to convert any portion of this Note in excess of that
 portion of this Note upon conversion of which the sum of (1) the number of shares of Common
 Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock
 which may be deemed beneficially owned through the ownership of the unconverted portion of
 the Notes or the unexercised or unconverted portion of any other security of the Borrower
 subject to a limitation on conversion or exercise analogous to the limitations contained
 herein) and (2) the number of shares of Common Stock issuable upon the conversion of the
 portion of this Note with respect to which the determination of this proviso is being made,
 would result in beneficial ownership by the Holder and its affiliates of more than 4.99%
 of the outstanding shares of Common Stock. For purposes of the proviso to the immediately
 preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d)
 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
 Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <u>The beneficial ownership limitations on conversion as set forth in the section may NOT be waived by the Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Upon
 delivery to the Borrower of a completed Notice of Conversion, a form of which is annexed
 hereto as Schedule A, Borrower shall issue and deliver to the Holder within five (5) business
 days after the Conversion Date (such fifth day being the "Delivery Date") that
 number of shares of Common Stock for the portion of the Note converted in accordance with
 the foregoing. The Holder will not be required to surrender the Note to the Borrower until
 the Note has been fully converted or satisfied. The number of shares of Common Stock to be
 issued upon each conversion of this Note shall be determined by dividing that portion of
 the principal of the Note and interest, if any, to be converted, by the Conversion Price.

c. If
 the Borrower at any time shall, by reclassification or otherwise, change the Common Stock
 into the same or a different number of securities of any class or classes that may be issued
 or outstanding, this Note, as to the unpaid principal portion thereof and accrued interest
 thereon, shall thereafter be deemed to evidence the right to purchase an adjusted number
 of such securities and kind of securities as would have been issuable as the result of such
 change with respect to the Common Stock immediately prior to such reclassification or other
 change.

d. If
 the shares of Common Stock are subdivided or combined into a greater or smaller number of
 shares of Common Stock, or if a dividend is paid on the Common Stock in shares of Common
 Stock, the Conversion Price shall be proportionately reduced in case of subdivision of shares
 or stock dividend or proportionately increased in the case of combination of shares, in each
 such case by the ratio which the total number of shares of Common Stock outstanding immediately
 after such event bears to the total number of shares of Common Stock outstanding immediately
 prior to such event. This Note shall bind the successors and assigns of the Borrower and
 shall injure to the benefit of the Lender, its successors and assigns. At the Borrower's
 discretion any outstanding advance may be converted to equity in the Company.

e. Whenever
 the Conversion Price is adjusted pursuant to the events above, the Borrower shall promptly
 but not later than the fifth (5th) business day after the effectiveness of the adjustment,
 provide notice to the Holder setting forth the Conversion Price after such adjustment and
 setting forth a statement of the facts requiring such adjustment. Failure to provide the
 foregoing notice is an Event of Default under this Note.

f. This
 Note may be converted by the Holder in whole or in part as described in Section 2.1(a) hereof.
 Upon partial conversion of this Note, a new Note containing the same date and provisions
 of this Note shall, at the request of the Holder, be issued by the Borrower to the Holder
 for the principal balance of this Note and interest which shall not have been converted or
 paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **Events of Default**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Events
 of Default. If any one or more of the following events ("Events of Default")
 shall occur and be continuing (and whether such occurrence shall be voluntary or involuntary
 or come about or be effected by operation of law or pursuant to or in compliance with any
 judgment, decree, or order of any court or any order, rule, or regulation of any administrative
 or governmental body), the Lender may, at its option, declare the Note to be immediately
 due and payable, whereupon the maturity of the then unpaid balance of the Note shall be accelerated
 and the same, together with all interest accrued thereon, shall forthwith become due and
 payable without presentment, demand, protest, or notice of any kind, all of which are hereby
 expressly waived, anything contained herein or in the Note to the contrary notwithstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. If
 default shall be made in the due and punctual payment of the principal or interest under
 the Note, when and as the same shall become due and payable, whether at maturity, by acceleration,
 or otherwise;

ii. If
 default shall be made in the performance or observance of, or shall occur under, any covenant,
 agreement, or other provision of this Agreement or in any instrument or document delivered
 to the Lender in connection with or pursuant to this Agreement, or if any such instrument
 or document shall terminate or become void or unenforceable without the written consent of
 the Lender;

iii. If
 default shall occur in the payment of any principal, interest, or other amount due with respect
 to any indebtedness for borrowed money, subordinated debt or other debt of the Borrower or
 under any agreement or instrument under or pursuant to which any such indebtedness, subordinated
 debt, or other debt may have been issued, created, assumed, or guaranteed by the Borrower
 and such default shall continue for more than the grace period, if any, therein specified,
 or if any such indebtedness, subordinated debt, or other debt be declared due and payable
 prior to the stated maturity thereof;

iv. If
 any representation or warranty or any other statement of fact herein or in any writing, certificate,
 report, or statement at any time furnished to the Lender pursuant to or in connection with
 this Agreement, or otherwise, shall be false or misleading in any material respect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. If the Borrower shall admit in writing its inability to pay its debts generally as they become
 due, file a petition in bankruptcy or a petition to take advantage of any insolvency act;
 make an assignment for the benefit of creditors; commence a proceeding for the appointment
 of a receiver, trustee, liquidator, or conservator of itself or of a whole or any substantial
 part of its property; file a petition or answer seeking reorganization or arrangement or
 similar relief under the United States federal bankruptcy laws or any similar law or statute
 of any state or country;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;vi. If
 the Borrower shall be adjudged a bankrupt; or a court of competent jurisdiction shall enter
 an order, judgment, or decree appointing a receiver, trustee, liquidator, or conservator
 of the Borrower or of the whole or any substantial part of its property, or approve a petition
 filed against the Borrower seeking reorganization or similar relief under the United States
 federal bankruptcy laws or any similar law or statute of any state or country, or if, under
 the provisions of any other law for the relief or aid of debtors, a court of competent jurisdiction
 shall assume custody or control of the Borrower or of the whole or any substantial part of
 its property; or if there is commenced against the Borrower any proceeding for any of the
 foregoing relief or if a petition in bankruptcy is filed against the Borrower and such proceeding
 or petition remains undismissed or unstayed for a period of ninety (90) days; or if the Borrower
 by any act indicates its consent to, approval of or acquiescence in any such proceeding or
 petition; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. **Suits for Enforcement.** If any one or more Events of Default shall occur and be continuing,
 the Lender may proceed to protect and enforce its rights or remedies either by suit in equity
 or by action at law, or both, whether for the specific performance of any covenant, agreement
 or other provision contained herein, in the Note, or in any document or instrument delivered
 in connection with or pursuant to this Agreement, or to enforce the payment of the Note or
 any other legal or equitable right or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. **Rights and Remedies Cumulative**. No right or remedy herein conferred upon the Lender is intended
 to be exclusive of any other right or remedy contained herein, in the Note, or in any instrument
 or document delivered in connection with or pursuant to this Agreement, and every such right
 or remedy shall be cumulative and shall be in addition to every other such right or remedy
 contained herein and therein or now or hereafter existing at law or in equity or by statute,
 or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. **Rights and Remedies Not Waived**. No course of dealing between the Borrower and the Lender or any failure or delay on the part of the Lender
in exercising any rights or remedies hereunder shall operate as a waiver of any rights or remedies of the Lender and no single or partial
exercise of any rights or remedies hereunder shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **Modification and Waiver**. No modification or waiver of any provision of the Note or of this Agreement
 and no consent by the Lender to any departure therefrom by the Borrower shall be effective
 unless such modification or waiver shall be in writing and signed by the Lender, and the
 same shall then be effective only for the period, on the conditions and for the specific
 instances and purposes specified in such writing. No notice to or demand on the Borrower
 in any case shall entitle the Borrower to any other or further notice or demand in similar
 or other circumstances.

5. **Corporate Obligation.** It is expressly understood that this Note is a corporate obligation of MDWerks,
 Inc., and is not guaranteed by any stockholder, officer or employee of MDWerks, Inc., and
 the Lender agrees to indemnify all stockholders, officers and employees of MDWerks, Inc.,
 for any and all obligations and liabilities associated with this Note.

6. **Benefit of Agreement**. This Agreement shall be binding upon and inure to the benefit of the Borrower
 and the Lender and their successors and assigns, and all subsequent holders of the Note.

7. **Notices.** All notices, requests, demands, or other communications provided for herein shall be in writing
 and shall be deemed to have been given when sent by registered or certified mail, return
 receipt requested, addressed to the parties, at the addresses set forth above, or to such
 other address as either party shall designate to the other from time to time in writing forwarded
 in like manner.

8. **Captions.** The captions of the various sections and paragraphs of this Agreement have been inserted
 only for the purposes of convenience; such captions are not a part of this Agreement and
 shall not be deemed in any manner to modify, explain, enlarge, or restrict any of the provisions
 of this Agreement.

9. **Applicable Law** This Note shall be governed by and construed in accordance with the laws of the State
 of Delaware, without giving effect to the laws, rules or principles of such State, regarding
 conflicts of laws. The Borrower and Lender each agree to the jurisdiction of the state and
 federal courts within the State of Delaware.

10. **Execution in Counterparts**. This Agreement may be executed in counterparts, all of which taken together
 shall be deemed one original.

[The remainder of this page has been intentionally left blank. Signature page follows.]

IN WITNESS WHEREOF, the parties hereto have set their hands and seals as of the day and year first set forth above.

---

| | |
|:---|:---|
| **BORROWER:** | **BORROWER:** |
| **MDWerks, Inc.** | **MDWerks, Inc.** |
| By: | /s/ Steven Laker |
| Its: | CEO |
| **LENDER:** | **LENDER:** |
|  | Richard Blackstone |
| By: | /s/ Richard Blackstone |
| An Individual | An Individual |

---

**<u>SCHEDULE A - NOTICE OF CONVERSION</u>**

(To be executed by the Registered Holder in order to convert the Note)

The undersigned hereby elects to convert $_________ of the principal and $_________ of the interest due on the Note issued by MDWERKS, INC. on ________ ___into Shares of Common Stock of MDWerks Inc. (the "Borrower") according to the conditions set forth in such Note, as of the date written below.

Date of Conversion:____________________________________________________________________

Conversion Price:______________________________________________________________________

Shares To Be Delivered:_________________________________________________________________

Signature:____________________________________________________________________________

Print Name:__________________________________________________________________________

Address:_____________________________________________________________________________

___________________________________________________________________________

## Exhibit 10.4

**Exhibit 10.4**

**CONVERTIBLE PROMISSORY NOTE**

**NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$15000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 15, 2026 |

---

**FOR VALUE RECEIVED**, MDWerks., Inc. a Delaware Corporation (the "Borrower"), hereby promises to pay to the order of <u>Joshua Blackstone</u> (the "Lender"), the principal sum of $15,000 (fifteen thousand dollars) or, if less *the* aggregate unpaid amount of all advances made by the Lender to the Borrower, together with interest, at a rate of 1.67% per month, (20% annually). This Note shall be due and payable, together with accrued but unpaid interest hereon, on October 15, 2026, or as otherwise agreed to in writing by the Borrower and Lender. The Value Received noted above consisted of $15,000 in cash paid to the Borrower by the Lender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **Repayment.** All Payments shall be applied, on a *pro rata* basis among outstanding advances,
 first to interest and then to the unpaid principal of this note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Borrower
 may prepay this Note in whole or in part at any time without penalty. Any and all prepayments
 shall be credited first to accrued interest on this Note to the date of the prepayment, on
 a *pro rata* basis among outstanding advances or to specific advances as designated
 by the Borrower, and then to the unpaid principal of this Note on *pro rata* basis among
 outstanding advances or to specific advances as designated by the Borrower.

b. Borrower
 waives diligence, demand, presentment of payment, notice of nonpayment, protest and notice
 of protest, and notice of any renewals or extensions of this Note and agrees that the time
 for payment of this Note may be extended at Lender's sole discretion without impairing
 its liability thereon. Any delay on the part of the Lender in exercising any right hereunder
 shall not operate as a waiver of any such right, and any waiver granted for one occasion
 shall not operate as a waiver in the event of any subsequent default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **Conversion Right.** The Holder shall have the right at any time commencing on the three month anniversary
 date of this Note, until this Note is fully paid, to convert any outstanding and unpaid principal
 portion of this Note, and accrued interest, at the election of the Holder (the date of giving
 of such notice of conversion being a "Conversion Date") into fully paid and nonassessable
 shares of $0.001 par value common stock of the Borrower ("Common Stock"). Subject
 to adjustment as provided below, the conversion price ("Conversion Price") per
 share shall be a price equal to $0.10 (ten cents) per share of the Company's Common
 Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. In
 no event shall the Holder be entitled to convert any portion of this Note in excess of that
 portion of this Note upon conversion of which the sum of (1) the number of shares of Common
 Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock
 which may be deemed beneficially owned through the ownership of the unconverted portion of
 the Notes or the unexercised or unconverted portion of any other security of the Borrower
 subject to a limitation on conversion or exercise analogous to the limitations contained
 herein) and (2) the number of shares of Common Stock issuable upon the conversion of the
 portion of this Note with respect to which the determination of this proviso is being made,
 would result in beneficial ownership by the Holder and its affiliates of more than 4.99%
 of the outstanding shares of Common Stock. For purposes of the proviso to the immediately
 preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d)
 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
 Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <u>The beneficial ownership limitations on conversion as set forth in the section may NOT be waived by the Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Upon
 delivery to the Borrower of a completed Notice of Conversion, a form of which is annexed
 hereto as Schedule A, Borrower shall issue and deliver to the Holder within five (5) business
 days after the Conversion Date (such fifth day being the "Delivery Date") that
 number of shares of Common Stock for the portion of the Note converted in accordance with
 the foregoing. The Holder will not be required to surrender the Note to the Borrower until
 the Note has been fully converted or satisfied. The number of shares of Common Stock to be
 issued upon each conversion of this Note shall be determined by dividing that portion of
 the principal of the Note and interest, if any, to be converted, by the Conversion Price.

c. If
 the Borrower at any time shall, by reclassification or otherwise, change the Common Stock
 into the same or a different number of securities of any class or classes that may be issued
 or outstanding, this Note, as to the unpaid principal portion thereof and accrued interest
 thereon, shall thereafter be deemed to evidence the right to purchase an adjusted number
 of such securities and kind of securities as would have been issuable as the result of such
 change with respect to the Common Stock immediately prior to such reclassification or other
 change.

d. If
 the shares of Common Stock are subdivided or combined into a greater or smaller number of
 shares of Common Stock, or if a dividend is paid on the Common Stock in shares of Common
 Stock, the Conversion Price shall be proportionately reduced in case of subdivision of shares
 or stock dividend or proportionately increased in the case of combination of shares, in each
 such case by the ratio which the total number of shares of Common Stock outstanding immediately
 after such event bears to the total number of shares of Common Stock outstanding immediately
 prior to such event. This Note shall bind the successors and assigns of the Borrower and
 shall injure to the benefit of the Lender, its successors and assigns. At the Borrower's
 discretion any outstanding advance may be converted to equity in the Company.

e. Whenever
 the Conversion Price is adjusted pursuant to the events above, the Borrower shall promptly
 but not later than the fifth (5th) business day after the effectiveness of the adjustment,
 provide notice to the Holder setting forth the Conversion Price after such adjustment and
 setting forth a statement of the facts requiring such adjustment. Failure to provide the
 foregoing notice is an Event of Default under this Note.

f. This
 Note may be converted by the Holder in whole or in part as described in Section 2.1(a) hereof.
 Upon partial conversion of this Note, a new Note containing the same date and provisions
 of this Note shall, at the request of the Holder, be issued by the Borrower to the Holder
 for the principal balance of this Note and interest which shall not have been converted or
 paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **Events of Default**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Events
 of Default. If any one or more of the following events ("Events of Default")
 shall occur and be continuing (and whether such occurrence shall be voluntary or involuntary
 or come about or be effected by operation of law or pursuant to or in compliance with any
 judgment, decree, or order of any court or any order, rule, or regulation of any administrative
 or governmental body), the Lender may, at its option, declare the Note to be immediately
 due and payable, whereupon the maturity of the then unpaid balance of the Note shall be accelerated
 and the same, together with all interest accrued thereon, shall forthwith become due and
 payable without presentment, demand, protest, or notice of any kind, all of which are hereby
 expressly waived, anything contained herein or in the Note to the contrary notwithstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. If
 default shall be made in the due and punctual payment of the principal or interest under
 the Note, when and as the same shall become due and payable, whether at maturity, by acceleration,
 or otherwise;

ii. If
 default shall be made in the performance or observance of, or shall occur under, any covenant,
 agreement, or other provision of this Agreement or in any instrument or document delivered
 to the Lender in connection with or pursuant to this Agreement, or if any such instrument
 or document shall terminate or become void or unenforceable without the written consent of
 the Lender;

iii. If
 default shall occur in the payment of any principal, interest, or other amount due with respect
 to any indebtedness for borrowed money, subordinated debt or other debt of the Borrower or
 under any agreement or instrument under or pursuant to which any such indebtedness, subordinated
 debt, or other debt may have been issued, created, assumed, or guaranteed by the Borrower
 and such default shall continue for more than the grace period, if any, therein specified,
 or if any such indebtedness, subordinated debt, or other debt be declared due and payable
 prior to the stated maturity thereof;

iv. If
 any representation or warranty or any other statement of fact herein or in any writing, certificate,
 report, or statement at any time furnished to the Lender pursuant to or in connection with
 this Agreement, or otherwise, shall be false or misleading in any material respect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. If the Borrower shall admit in writing its inability to pay its debts generally as they become
 due, file a petition in bankruptcy or a petition to take advantage of any insolvency act;
 make an assignment for the benefit of creditors; commence a proceeding for the appointment
 of a receiver, trustee, liquidator, or conservator of itself or of a whole or any substantial
 part of its property; file a petition or answer seeking reorganization or arrangement or
 similar relief under the United States federal bankruptcy laws or any similar law or statute
 of any state or country;

vi. If
 the Borrower shall be adjudged a bankrupt; or a court of competent jurisdiction shall enter
 an order, judgment, or decree appointing a receiver, trustee, liquidator, or conservator
 of the Borrower or of the whole or any substantial part of its property, or approve a petition
 filed against the Borrower seeking reorganization or similar relief under the United States
 federal bankruptcy laws or any similar law or statute of any state or country, or if, under
 the provisions of any other law for the relief or aid of debtors, a court of competent jurisdiction
 shall assume custody or control of the Borrower or of the whole or any substantial part of
 its property; or if there is commenced against the Borrower any proceeding for any of the
 foregoing relief or if a petition in bankruptcy is filed against the Borrower and such proceeding
 or petition remains undismissed or unstayed for a period of ninety (90) days; or if the Borrower
 by any act indicates its consent to, approval of or acquiescence in any such proceeding or
 petition; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. **Suits for Enforcement.** If any one or more Events of Default shall occur and be continuing,
 the Lender may proceed to protect and enforce its rights or remedies either by suit in equity
 or by action at law, or both, whether for the specific performance of any covenant, agreement
 or other provision contained herein, in the Note, or in any document or instrument delivered
 in connection with or pursuant to this Agreement, or to enforce the payment of the Note or
 any other legal or equitable right or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. **Rights and Remedies Cumulative**. No right or remedy herein conferred upon the Lender is intended
 to be exclusive of any other right or remedy contained herein, in the Note, or in any instrument
 or document delivered in connection with or pursuant to this Agreement, and every such right
 or remedy shall be cumulative and shall be in addition to every other such right or remedy
 contained herein and therein or now or hereafter existing at law or in equity or by statute,
 or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. **Rights and Remedies Not Waived**. No course of dealing between the Borrower and the Lender or any failure or delay on the part of the Lender
in exercising any rights or remedies hereunder shall operate as a waiver of any rights or remedies of the Lender and no single or partial
exercise of any rights or remedies hereunder shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **Modification and Waiver**. No modification or waiver of any provision of the Note or of this Agreement
 and no consent by the Lender to any departure therefrom by the Borrower shall be effective
 unless such modification or waiver shall be in writing and signed by the Lender, and the
 same shall then be effective only for the period, on the conditions and for the specific
 instances and purposes specified in such writing. No notice to or demand on the Borrower
 in any case shall entitle the Borrower to any other or further notice or demand in similar
 or other circumstances.

5. **Corporate Obligation.** It is expressly understood that this Note is a corporate obligation of MDWerks,
 Inc., and is not guaranteed by any stockholder, officer or employee of MDWerks, Inc., and
 the Lender agrees to indemnify all stockholders, officers and employees of MDWerks, Inc.,
 for any and all obligations and liabilities associated with this Note.

6. **Benefit of Agreement**. This Agreement shall be binding upon and inure to the benefit of the Borrower
 and the Lender and their successors and assigns, and all subsequent holders of the Note.

7. **Notices.** All notices, requests, demands, or other communications provided for herein shall be in writing
 and shall be deemed to have been given when sent by registered or certified mail, return
 receipt requested, addressed to the parties, at the addresses set forth above, or to such
 other address as either party shall designate to the other from time to time in writing forwarded
 in like manner.

8. **Captions.** The captions of the various sections and paragraphs of this Agreement have been inserted
 only for the purposes of convenience; such captions are not a part of this Agreement and
 shall not be deemed in any manner to modify, explain, enlarge, or restrict any of the provisions
 of this Agreement.

9. **Applicable Law** This Note shall be governed by and construed in accordance with the laws of the State
 of Delaware, without giving effect to the laws, rules or principles of such State, regarding
 conflicts of laws. The Borrower and Lender each agree to the jurisdiction of the state and
 federal courts within the State of Delaware.

10. **Execution in Counterparts**. This Agreement may be executed in counterparts, all of which taken together
 shall be deemed one original.

[The remainder of this page has been intentionally left blank. Signature page follows.]

IN WITNESS WHEREOF, the parties hereto have set their hands and seals as of the day and year first set forth above.

---

| | |
|:---|:---|
| **BORROWER:** | **BORROWER:** |
| **MDWerks, Inc.** | **MDWerks, Inc.** |
| By: | /s/ Steven Laker |
| Its: | CEO |
| **LENDER:** | **LENDER:** |
|  | **Joshua Blackstone** |
| By: | /s/ Joshua Blackstone |
| An Individual | An Individual |

---

**<u>SCHEDULE A - NOTICE OF CONVERSION</u>**

(To be executed by the Registered Holder in order to convert the Note)

The undersigned hereby elects to convert $_________ of the principal and $_________ of the interest due on the Note issued by MDWERKS, INC. on ________ ___into Shares of Common Stock of MDWerks Inc. (the "Borrower") according to the conditions set forth in such Note, as of the date written below.

Date of Conversion:____________________________________________________________________

Conversion Price:______________________________________________________________________

Shares To Be Delivered:_________________________________________________________________

Signature:____________________________________________________________________________

Print Name:__________________________________________________________________________

Address:_____________________________________________________________________________

___________________________________________________________________________

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS**

I, Steven C. Laker, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of MDWerks, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 15, 2026 |
| */s/ Steven C. Laker* |
| Steven C. Laker |
| Chief Executive Officer |
| (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATIONS**

I, David Stephens, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of MDWerks, Inc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 15, 2026 |
| */s/ David Stephens* |
| David Stephens |
| Chief Financial Officer |
| (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of MDWerks, Inc. (the "Company") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission (the "Report"), I, Steven C. Laker, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | |
|:---|:---|
| Date: May 15, 2026 | */s/ Steven C. Laker* |
|  | Steven C. Laker<br> Chief Executive Officer<br> (Principal Executive Officer) |

---

*This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.*

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of MDWerks, Inc. (the "Company") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission (the "Report"), I, David Stephens, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | |
|:---|:---|
| Date: May 15, 2026 | */s/ David Stephens* |
|  | David Stephens<br> Chief Financial Officer<br> (Principal Financial Officer) |

---

*This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.*